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Summary
     SUMMARY 
 
 
Congenital diaphragmatic hernia (CDH) still causes high mortality in newborns because 
of severe respiratory failure secondary to pulmonary hypoplasia. In addition, the 
ensuing chronic pulmonary disease continues to be the most significant source of 
morbidity in survivors. Pulmonary hypoplasia and lung injury caused by mechanical 
ventilation have been recognized as the major determinants of respiratory morbidity. 
However, pulmonary symptoms are also experienced by patients with mild to 
moderate lung hypoplasia, suggesting that other causes might be involved. Autonomic 
nerves control tracheobronchial smooth muscle whose contractility modulates lung 
growth and regulates airway patency. We therefore hypothesized that impaired 
trachebronchial innervation might interfere with lung development and contribute to 
induce long-term bronchopulmonary symptoms.  
Using the nitrofen experimental rat model of CDH, we studied the tracheobronchial 
innervation and we were able to demonstrate that it was deficient in embryos and 
fetuses with CDH. We investigated the development of the tracheobronchial 
innervation, pointing out that it was delayed in embryos and fetuses with CDH and that 
the neural deficiency was partially compensated by an increase of the supporting glial 
tissue. In an attempt to translate these findings to the human condition as a partial 
explanation for chronic lung disease of survivors, we looked for the same lesions in 
infants with CDH and could confirm their presence. 
We then undertook to demonstrate that prenatal interventions could improve the 
above-mentioned deficiencies and demonstrated in cultured hypoplastic rat lungs that 
both the deficient bronchial innervation and the poor tracheobronchial peristalsis 
could be rescued by the addition of retinoic acid.  
Finally, we explored in vitro, in cultured lung explants, and in vivo, using intra-amniotic 
injection, the possible beneficial effects of amniotic fluid stem cells on hypoplastic 
lungs and demonstrated the viability of this approach. 
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La hernia diafragmática congénita sigue causando una elevada mortalidad en recién 
nacidos debido a la insuficiencia respiratoria grave secundaria a hipoplasia pulmonar. 
Las secuelas respiratorias crónicas siguen siendo la fuente más significativa de 
morbilidad entre los supervivientes. La hipoplasia pulmonar y el daño pulmonar 
causado por la ventilación mecánica son las principales causas de morbilidad 
respiratoria. Sin embargo también hay sintomatología respiratoria en pacientes con 
hipoplasia pulmonar moderada o leve, sugiriendo que podrían estar involucradas otras 
causas. La inervación autónoma regula el músculo liso traqueobronquial cuyo 
peristaltismo modula el crecimiento pulmonar y regula la permeabilidad del las vías 
aereas. Por estas razones pusimos a prueba la hipótesis de que alteraciones de la 
inervación traqueobronquial podrían interferir con el desarrollo pulmonar y contribuir 
a inducir secuelas respiratorias a largo plazo. 
Utilizando el modelo experimental de hernia diafragmática congénita obtenido a 
través de la administratión de nitrofen a la rata, estudiamos la inervación 
traqueobronquial y demonstramos que estaba alterada en embriones y fetos con 
hernia diafragmática congénita. Investigamos el desarrollo de la inervación 
traqueobronquial y demonstramos que estaba retrasado en embriones y fetos con 
hernia diafragmática congénita y que el defecto de la inervación estaba parcialmente 
compensado por un aumento del tejido glial de soporte. En un intento de trasladar 
estos hallazgos a la clínica para explicar parcialmente la patología respiratoria crónica 
de los supervivientes, investigamos la presencia de las mismas alteraciones en recién 
nacidos con hernia diafragmática congénita y pudimos confirmarla. 
A continuación, intentamos demonstrar que ciertas intervenciones prenatales pueden 
mejorar las deficiencias antes mencionadas y pudimos confirmar en cultivos de 
pulmones de rata que tanto las alteraciones de la inervación bronquial como la 
deficiencia de la peristalsis traqueobronquial pueden ser rescatadas por la adición de 
ácido retionoico. 
Finalmente analizamos in vitro, en cultivos de explantes de pulmón, e in vivo,
mediante la inyección intra-amniótica, los posibles efectos beneficiosos de células 
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madre de origen amniótico sobre la hipoplasia pulmonar y demostramos la viabilidad 
de este enfoque. 
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AChe: acetylcholinesterase 
AECs-II: alveolar epithelial cells type II 
AFS: amniotic fluid-derived stem (cells) 
ASM: airway smooth muscle 
BCA: bicinchoninic acid 
CDH: congenital diaphragmatic hernia 
cDNA: complementary DNA 
CO2: carbon dioxide 
CT: cycle threshold 
DEPC: diethylpyrocarbonate 
D-MEM or DMEM: Dulbecco's Modified Eagle Medium 
D-MEM/F12: Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12  
DNA: deoxyribonucleic acid 
dNTPs: deoxynucleotide triphosphates 
DTT: dithiothreitol 
E0, E9.5, E13, E15, E18 and  E21: gestational day 0, 9.5, 13, 15, 18 and 21 
EDNRB: endothelin receptor type B 
FBS: fetal bovine serum 
FGF10: fibroblast growth factor 10 
GER:  gastroesophageal reflux  
GFP: green fluorescent protein 
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GDNF: glial derived neurotrophic factor  
h: hours 
HBSS: Hank’s buffer saline 
ICC: cells of Cajal 
IgG: immunoglobulin G 
IU: international unit 
kD or kDa: kilodalton 
L: litre 
MEM: minimum essential medium 
mg: milligram 
min: minutes 
mL or ml: milliliter 
mol: mole 
mm
2
: square millimeter 
mmol: millimole 
mRNA: messenger ribonucleic acid 
n: number 
NF: neurofilament 
ng: nanogram 
NGFR: nerve growth factor receptor 
nm: nanometer 
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p75
NTR
: low affinity neurotrophin receptor 
PBS: phosphate buffered saline 
PC: personal computer 
PCR: polymerase chain reaction 
PGP 9.5: protein gene product 9.5 
PVDF: polyvinylidene fluoride 
RA: retinoic acid 
RALDH 2: retinaldehyde dehydrogenase type 2 
RBL: rat basophilic leukemia 
RBP: retinol binding protein 
RET: REarranged during Transfection 
RNA: ribonucleic acid 
RT-PCR: real time polymerase chain reaction 
S100B: S100 calcium binding protein B 
SD: standard deviation 
SDS: sodium dodecyl sulfate 
SOD: superoxide dismutase 
Sox10: SRY (sex determining region Y)-box 10 
STRA6: stimulated by retinoic acid gene 6 homolog 
Taq: thermus aquaticus 
???????????????????????????????????????? 
     INDEX OF ABBREVIATIONS 
 
5 
 
TTF-1: thyroid transcription factor-1 
??????????????????????????????????????????? 
vs: versus 
?g: microgram 
?l: microliter 
?m: micrometer 
?m2: square micrometer 
?M: micromole 
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1. CONGENITAL DIAPHRAGMATIC HERNIA 
Congenital diaphragmatic hernia (CDH) is a malformation characterized by a 
posterolateral defect of the diaphragm, that allows herniation of abdominal viscera 
into the thoracic cavity. Left-sided hernia occurs in approximately 80% of cases, in 
which the entire gastrointestinal tract, the left lobe of the liver, the spleen and the 
kidneys can go up into the thorax. In right-sided hernias (20% of the cases), only the 
liver and a portion of the intestine tend to herniate. Bilateral hernias are uncommon 
and usually fatal. CDH occurs in 1 in every 2500 live births 
1
.  
Mortality has traditionally been difficult to determine because of the “hidden 
mortality”, which refers to infants with the congenital malformation who die in utero 
or shortly after birth, prior to transfer to a surgical center. The Northern Region 
Congenital Abnormalities Survey database recorded in the UK between 1991 and 2001 
a mortality of 62%, that was unaffected by the introduction of new therapies 
2
. A 
population-based study from Western Australia indicated that only 61% of infants with 
CDH are live born and nearly 33% of pregnancies were electively terminated, mostly 
(71%) because of the presence of another major anomaly 
3
.  
Mortality after live birth is generally reported to range from 40-62%, and some authors 
argue that the true mortality of CDH has not changed with introduction of new 
therapies 
4, 5
. The presence of associated anomalies has consistently been associated 
with decreased survival; other predictors of poor outcome are prenatal diagnosis, 
prematurity, low birth weight and early pneumothorax. 
Over the past twenty years, pulmonary hypertension and pulmonary hypoplasia have 
been recognized as the two cornerstones of the pathophysiology of this malformation. 
CDH is characterized by a variable degree of pulmonary hypoplasia with bronchi of 
reduced size and branching associated with a decrease in cross-sectional area of the 
pulmonary vasculature and alterations of the surfactant system 
6
. The number of 
normal bronchi is reduced in the ipsilateral lung and to a lesser degree in the 
contralateral one 
7, 8
. The lungs have a reduced surface of alveolar-capillary membrane 
for gas exchange, which may be further decreased by surfactant dysfunction. In 
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addition to parenchymal disease, increased muscularization of the intraacinar 
pulmonary arteries appears to occur. Pulmonary capillary blood flow is decreased 
because of the small cross-sectional area of the pulmonary vascular bed, and flow may 
be further decreased by abnormal pulmonary vasoconstriction 
9
.  
 
2. LONG TERM PULMONARY MORBIDITY 
With improvements in neonatal intensive care and surgical management, an increased 
proportion of infants with severe forms of CDH survives. As a consequence, a higher 
rate of long-term sequelae and chronic morbidity have been described in these 
patients. Among others, pulmonary morbidity and gastroesophageal reflux (GER) are 
the most frequent contributors to overall morbidity in survivors of CDH, although the 
underlying mechanisms have not yet been fully understood. The structural 
abnormalities of distal airways associated with lung hypoplasia and barotrauma due to 
mechanical ventilation have been advocated as possible causes of the pulmonary 
sequelae. Due to their reduced pulmonary reserve, CDH survivors tend to suffer more 
severely from viral respiratory infections in their first year of life, also when the degree 
of pulmonary hypoplasia was described as mild to moderate 
10
. After this period, most 
patients are able to lead normal o near-normal lives without significant respiratory 
morbidity, including participation in regular physical activity 
11-13
. However, some 
children still require oxygen supplementation at two years of age 
14
. Some of them 
experience recurrent bronchitis and fail to thrive 
15
. Pulmonary function studies 
generally revealed mild to moderate airway obstruction with a tendency towards 
hyperinflation and a decreased inspiratory muscle strength. It has been hypothesized 
that the reduced lung tissue and the consequent alveolar distension may result in early 
airway closure as found in the aging emphysematous lung, which could be an 
additional risk factor in the development of chronic obstructive disease on the longer 
term 
16, 17
. However, patients with normal lung function and restrictive pattern of 
changes have also been described 
11, 12, 18
. Lung volumes were mostly found to be 
normal or near-normal and diffusion capacity was shown to be within normal limits 
11, 
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18, 19
. Although patients surviving CDH do not have many respiratory symptoms in their 
school year, the majority of them have some degree of obstructive and/or restrictive 
airway disease when carefully examined 
20
. Lung morphology studies after CDH repair 
describe a striking increase in alveolar size, especially on the side of the former defect 
21
. This indicates some degree of distension of the parenchyma to fill the hemithorax 
after repair and suggests that compensatory alveolar multiplication, if occurring at all, 
fails to normalize alveolar numbers 
16
. There is a high prevalence of airway 
hyperresponsiveness in CDH survivors 
11, 18
. In contrast to patients with bronchial 
asthma, CDH survivors tend to respond positively to pharmacological challenges like 
methacholine but not to metabisulfite, suggesting that their bronchial 
hyperresponsiveness might arise from an altered airway geometry 
12
. As most 
neonates with CDH require complex pre- and postoperative intensive care, often 
including prolonged artificial ventilation, some of the observed residual defects might 
rather stem from this mechanical ventilation and oxygen toxicity than the 
malformation itself. A study compared the long-term outcome of CDH survivors with 
that of patients without CDH, who had undergone comparable intensive care and 
mechanical ventilation as newborns 
18
. Mild airway obstruction was found in both 
groups with more peripheral airway obstruction in CDH patients than in controls. Thus, 
the authors suggested that both residual lung hypoplasia and neonatal intensive care 
are important determinants of persistent lung function abnormalities in CDH survivors. 
 
3. EMBRYOLOGY OF THE TRACHEOBRONCHIAL TREE 
The mammalian lung develops as a ventral outgrowth of the endodermal foregut, the 
respiratory diverticulum or lung bud, that begins to grow ventrocaudally through the 
surrounding splanchnic mesenchyme. The septation of the respiratory and digestive 
tracts occur differently in rat and human embryos. In rats, at 11.5 days of gestation 
two paired endodermal buds grow out of the primitive foregut and, as they elongate, 
the primitive foregut splits into two tubes, the dorsal esophagus and the ventral 
trachea 
22
. In human, however, the trachea is first separated from the esophagus by 
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the laryngotracheal groove, which extends ventrally from the floor to the pharynx, 
then progresses anteriorly to divide the foregut dorsally into the esophagus and 
ventrally into the trachea. After elongation of the tracheal outgrowth, during the 3
rd 
- 
4
th
 week of gestation, the caudal end of the laryngotracheal groove undergoes a first 
bifurcation, splitting into right and left primary bronchial buds, that are the rudiments 
of the two lungs 
23, 24
. Between the 5
th
 and the 28
th
 week of gestation they continue to 
elongate and branch until the entire respiratory tree is formed. The mesenchyme that 
surrounds the developing trachea and bronchi gives origin to the bronchial 
musculature, the cartilaginous rings and the pulmonary connective tissue. The right 
lung of the rat is made up of four major lobes, the cranial, the medial, the accessory 
and the caudal, whereas the left lung consists of only one small lobe 
22, 24
. In human, 
the right lung has three lobes, the upper, the middle and the lower, whereas the left 
lung is composed of two lobes, the upper and the lower. 
Four histological stages can be distinguished during human lung development (table 
1): pseudoglandular, canalicular, saccular and alveolar. The pseudoglandular stage 
takes place between the 6
th
 and the 16
th
 weeks of gestation. The bronchial tree is 
formed by the repeated dichotomous branching of the developing epithelium into the 
surrounding mesenchyme. The branching is complete at 16 generations by the 16
th
 
week of gestation in humans. After this stage, further growth occurs only by 
elongation and widening of existing airways. In the canalicular phase, between the 16
th
 
and the 28
th
 week of gestation, each terminal bronchiole divides into two or more 
respiratory bronchioles and the respiratory vasculature begins to develop. From 28
th
 
week of gestation until term, during the saccular stage, the respiratory bronchioles 
subdivide to produce terminal sacs, the primitive alveoli, that continue to be produced 
until childhood. In the same period, the differentiation of type I and type II 
pneumocytes takes place. Finally, around the 36
th
 week of gestation, in the alveolar 
phase, there is a huge multiplication of the alveoli establishing an extensive surface 
area. At birth, human neonates have entered the alveolar stage of development. Over 
85% of alveoli are formed after birth by a process of air space septation. During early 
development, lung surface area increases because of the increase of the number of 
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alveoli; during later development stages, there is an expansion of the airspace of the 
lung. The increase in number and surface area of the alveoli begins to level off 
between the ages of 2 to 4 years. The timing in which alveolization is considered 
complete in humans ranges from 2 to 8 years. In contrast, rats are born during the 
saccular stage and reach the alveolar stage at 4 days of life. Most of the lung 
development is complete within the 2
nd
 week after birth. Furthermore, the rat lung 
continues to proliferate at a slow rate throughout its life 
25, 26
. 
TABLE 1. 
The table illustrates the stages of lung development in human and rat lung in gestation 
days 
25
. 
 
SPECIES 
 
GLANDULAR 
 
CANALICULAR 
 
 
SACCULAR 
 
ALVEOLAR 
 
HUMAN 
 
42-112 
 
112-196 
 
 
196-252 
 
252-childhood 
 
RAT 
 
13-18 
 
19-20 
 
21-birth 
 
Postnatal days 
7-21 
 
4. INNERVATION OF THE TRACHEOBRONCHIAL TREE 
The respiratory tract is regulated by autonomic nerves, that control the smooth muscle 
tone, the submucosal gland secretion, the epithelial cell function, the bronchial 
vascular tone and the tracheobronchial reflexes. Shortly after separating from the 
foregut, the developing tubules are surrounded by smooth muscle and ensheathed in a 
network of newly forming nervous tissue. Two large nerve trunks lying in the 
adventitial surface of the airway wall run along the bronchial tree and give rise to a 
network of bundles with fine varicose fibers covering the airway smooth muscle from 
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the trachea to the growing tips of the airways and some nerves penetrate the smooth 
muscle layer. The maturation of the nerve trunks and the ganglia occurs centrifugally 
in the bronchial tree 
27
. Because the neural crest cells that will populate the gut are 
already present in the foregut at the time when the lung buds emerge, it had been 
postulated that these cells migrated into the lung as it was forming. The 
tracheobronchial cells’ positive staining with p75
NTR
 antibody 
27
, a neural crest-derived 
cell marker, supported this theory, which was demonstrated unequivocally in 2005 by 
A. J. Burns and J. M. Delalande. Using the quail-chick grafting technique, they showed 
that vagal neural crest cells, that express the transcription factor Sox10 and receptor 
components of the RET and EDNRB signaling pathways, migrate from the foregut into 
the developing lung buds, where they accumulate to form interconnected ganglia 
containing neurons and glial cells 
28
. The same results were later confirmed using the 
embryonic mouse lung 
29
. The enteric neural crest cells are dependent on glial derived 
neurotrophic factor (GDNF) 
30
. In the same way as for the gut, GDNF and other ligands 
of the same family are likely to be important in guidance, differentiation and survival 
of pulmonary neurons 
31
. 
 
5. AIRWAY SMOOTH MUSCLE AND ITS RELATIONSHIP TO LUNG INNERVATION 
Both neural tissue and airway smooth muscle (ASM) are an integral part of the 
branching epithelial tubules from the onset of the lung development. Smooth muscle 
forms a layer of cells which encircles the epithelial tubules to their growing tips, an 
arrangement whereby the ASM tone would have the potential to produce narrowing 
and relaxation 
27
. Some authors first observed spontaneous narrowing of the airways 
in freshly excised human and pig lung 
32-34
 from the first trimester onward and in lung 
explants from fetal guinea pig, fetal mouse 
35
 and chick embryos. It became later clear 
that shortly after differentiation, the smooth muscle was able to respond strongly to 
agonists such as acetylcholine and histamine as well as to electrical field stimulation. 
The airway narrowing in response to neural stimulation was blocked by atropine and 
tetrodotoxin, indicating that functional cholinergic nerves were involved 
33
. 
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Spontaneous intermittent narrowing of the bronchi has been observed both in vivo 
and in vitro 
36
. The spontaneous contractions moved the lung liquid backward and 
forward along the airway lumen. The fluid pressure and the stress forces acting on the 
walls of the bronchial tree have been suggested to provide the mechanical stimulus for 
lung growth. When lung liquid is drained and hence the pressure is decreased, the lung 
becomes hypoplastic 
37
; in contrast, tracheal occlusion increases the pressure and 
enhances lung growth 
38
. It has been observed that spontaneous contractions of the 
airways are unaffected by either atropine or tetrodotoxin 
36
. The first finding indicates 
that neural activity is not essential, the latter shows that endogenous Ach is not 
involved. In addition, this rhythmic mechanical activity ceases in the presence of 
calcium antagonists. The authors concluded that spontaneous contractions are 
therefore of likely myogenic origin 
36
. Hence, since it seems unlikely at this early stage 
that impulses from the central nervous system come down the vagus, it has been 
supposed that the role fulfilled by neural tissue in early gestation is not 
neurotransmission, but rather secretion of trophic factors for the smooth muscle that 
indirectly contributes to lung development 
33, 36, 39, 40
. The nerves secrete trophic 
factors that influence growth and survival of the smooth muscle. In turn, the target 
tissue may provide a feedback by secreting neurotrophin, that helps nerves to survive 
and may influence the phenotypic expression of the neurotransmitters secreted during 
development 
31, 33
. Positive immunostaining for neurotransmitters, like choline 
acetyltransferase 
41
, calcitonin gene-related peptide 
42
, nitric oxid synthase, vasoactive 
intestinal peptide and substance P, can be seen in the varicosities of the nerve fibers 
lying on smooth muscle cells later in gestation, by the end of pseudoglandular and 
during canalicular stages 
40, 43
. The same authors 
36, 40, 43
 proposed the idea that the 
spontaneous contractions produce a rhythmic mechanical stimulus across the airway 
wall and the adjacent parenchyma that contributes to normal airway differentiation 
and branching by inducing expression of growth factors. Neurotrophic factors, like 
neurturin, a member of GDNF-family, and GDNF, have been isolated in airway smooth 
muscle cells or in the associated mesenchymal cells 
31, 44, 45
. The picture that emerges is 
that airway smooth muscle and neural tissue are an Integral part of the lung from the 
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onset of its development. They exist in a dynamic relationship throughout gestation 
and persist as an integral part of the airways into postnatal life 
40
.  
 
6. IN VITRO LUNG CULTURE 
In the freshly isolated bronchial tree of fetal pigs and rabbits, spontaneous 
contractions were observed in proximal and distal airways. The onset of rhythmic 
contractions was rapid and they continued for more than one minute before 
weakening and disappearing to start again at a different part of the bronchial tree 
32
. 
Likewise, in fetal lung explants in culture weak and infrequent spontaneous activities 
were observed after twenty four hours. By two days, strong waves of narrowing were 
observed along the main lobar bronchi and collaterals extending to the terminal sacs 
36
. At the first moment of the contraction the liquid is pushed equally in both 
directions, but as the wave of contraction begins to move distally, most of the liquid 
follows this direction rather than moving proximally. The walls of the terminal buds 
comprise a single layer of undifferentiated epithelial cells, so they are likely to be more 
compliant than the airways and able to accommodate the minute volume of liquid 
moved. Upon relaxation of the airway wall after the spontaneous contraction, the 
liquid moves back and the terminal buds return to their normal volume. For most 
contractions, the time between each one was long enough to allow a complete flow 
back 
36
. The frequency and the strength of the contractions were strongly 
temperature-dependant.
35
  
Embryonic lung explants can undergo branching morphogenesis in culture. This in vitro 
lung culture model 
31, 36, 46
 has proved to be an useful tool to investigate lung 
development and has the advantage of allowing easy changes of lung environment by 
modifying the composition of the medium. Using this model, it has been demonstrated 
that bronchial peristalsis is deficient in hypoplastic nitrofen-exposed lung explants 
47
.  
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7. THE RETINOID HYPOTHESIS 
The etiology of CDH is poorly understood. The “retinoid hypothesis” proposes that 
abnormalities in retinoid signaling or related pathways, contribute to abnormal 
development of the diaphragm. This hypothesis was formulated on the basis of animal 
data showing an association between the occurrence of diaphragmatic hernia and 
vitamin A deficiency, loss of retinoid receptor expression and exposure to teratogens 
that interfere with the synthesis of retinoic acid 
48
. CDH has also been recently linked 
with a human mutation in the retinol binding protein receptor, STRA6 
49, 50
. Retinoids 
are the family of molecules derived from vitamin A, whose source are the carotinoids 
from fruits and vegetables and the retinyl esters from animal meat. After absorption 
through the gut, retinyl esters are transported in chylomicrons to the liver for storage, 
where they are metabolized into retinol. Retinol bound to retinol-binding protein is 
transferred from the liver via blood to target cells. Within cells, retinol bound to 
cellular retinol-binding proteins is converted to retinal by retinol dehydrogenase 
followed by a further dehydrogenation to retinoic acid (RA). RA exerts its biological 
effects through binding the nuclear retinoic acid receptors and the nuclear retinoid X 
receptor 
51-53
. 
Different studies reveal the role of a retinoid signaling pathway disruption in the 
pathogenesis of CDH 
54-59
. Most of them have focused on the diaphragm and the 
reduction of the incidence of CDH after administration of vitamin A and its derivatives. 
However, other authors have demonstrated that antenatal administration of vitamin A 
and RA attenuates lung hypoplasia by interfering with early determinants of lung 
underdevelopment, suggesting that retinoids could also be implicated in the 
pathogenesis of lung hypoplasia 
60-65
. 
 
8. STEM CELLS 
Amniotic fluid-derived stem (AFS) cells are multipotent cells that can be isolated from 
human and rodent amniotic fluid and are able to differentiate into multiple lineages 
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including representatives of all three embryonic germ layers 
66
. The same cells can also 
engraft in irradiated bone marrow and give rise to all hematopoietic lineages 
67
. 
Remarkable results have been obtained in injured kidneys, heart and lungs 
68-70
. Finally, 
they can functionally contribute to the regeneration of various tissues and organs 
when transplanted in models of disease. The latter have been explored both in models 
of diseases and during development. A basal level of engraftment without 
differentiation was demonstrated after administration of AFS cells in uninjured lung. In 
contrast, in presence of lung damage, not only a significantly stronger engraftment 
was registered, but also the cells differentiate in specialised pneumocytes contributing 
and supplementing endogenous lung repair mechanisms 
71
. It was initially 
hypothesized that stem cells undid irreversible cellular damage and rebuilt injured or 
diseased tissue by differentiating into the phenotype of injured tissue, repopulating 
the diseased organ with healthy cells and hence improving the function. However, 
recent research suggests that stem cells may influence recovery from injury via 
paracrine factors that promote tissue repair 
72
. 
 
  
 Hypotheses
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1. The long term pulmonary morbidity observed in survivors of CDH might be 
partially explained by abnormalities of tracheobronchial innervation. 
2. Abnormal tracheobronchial innervation could explain hypoperistalsis observed 
in cultured hypoplastic lungs. 
3. Agents able to rescue lung hypoplasia in culture, like RA, could act by improving 
bronchial innervation and peristalsis. 
4. Pluripotent AFS cells might rescue growth and motility of hypoplastic lungs in 
vitro and in vivo. 
 
 
 
 
 
  
 Aims
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1. To demonstrate abnormal tracheobronchial innervation in rat embryos and 
fetuses with CDH. 
2. To examine the development of this innervation during fetal life to characterize 
the nature of the anomalies. 
3. To examine bronchopulmonary innervation in infants with CDH in a search for 
similar anomalies. 
4. To demonstrate that deficient tracheobronchial innervation could partially 
account for pulmonary hypoplasia in CDH. 
5. To examine whether rescue of lung hypoplasia by RA in vitro, is accompanied 
by rescue of bronchial innervation and peristalsis. 
6. To study if AFS cells could rescue growth and motility of hypoplastic lungs in 
vitro and in vivo. 
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Abstract
Background: Tracheobronchial motility influences lung development. Lung hypoplasia and lung
sequelae accompany congenital diaphragmatic hernia (CDH) in which the vagus nerves and esophageal
innervation are abnormal. As the vagus supplies tracheal innervation, this study tested the hypothesis
that it might also be abnormal in rats with CDH.
Material and Methods: Intrinsic ganglia were counted and measured in whole mount acetylcholinester-
ase-stained tracheas from CDH and control E21 fetal rats. The relative surfaces occupied by neural
structures were measured in tracheal sections immunostained for p75NTR and PGP 9.5. PGP 9.5 protein
and mRNA expression were determined. Mann-Whitney tests were used for comparisons between
groups using P b .05 as significant.
Results: p75NTR staining showed the neural crest origin of tracheal innervation. Scarce neural structures
and smaller ganglia were found in CDH fetuses. PGP 9.5 protein expression was decreased in CDH
fetuses, whereas PGP 9.5 mRNA levels were increased in comparison with controls.
Conclusions: Decreased density of neural structures and size of intramural ganglia, reduced expression
of neural tissue and PGP 9.5 protein, and increased levels of PGP 9.5 mRNA reveal deficient tracheal
innervation in rats with CDH. If similar anomalies exist in the human condition, they could contribute to
explaining the pathogenesis of lung hypoplasia and bronchopulmonary sequelae.
© 2009 Elsevier Inc. All rights reserved.
Long-term pulmonary morbidity occurs often in survivors
of congenital diaphragmatic hernia (CDH) as sequelae of
pulmonary hypoplasia and barotrauma owing to mechanical
ventilation. However, other causes might account for these
symptoms, as frequent respiratory tract infections, asthma, or
airway obstruction occurs also in cases with only mild to
moderate pulmonary hypoplasia [1-3]. Mesenchymal-epithe-
lial interactions are known to play a significant role in lung
morphogenesis [4,5], but, apparently, tracheobronchial
peristalsis operated by smooth muscle participates as well
[6,7]. Tracheobronchial innervation, concentrated mainly in
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the membranous posterior wall and distributed in adventitial
and submucosal plexuses, is of vagal origin [8]. As vagus
nerves and esophageal intrinsic innervation are abnormal in
babies [9] and in rats with CDH [10], in the present study we
undertook to test the hypothesis that tracheal innervation
might be abnormal in rat fetuses with CDH.
1. Material and methods
Adult Sprague-Dawley female rats were mated overnight.
Twelve hours later, the presence of spermatozoids in the
vaginal smear was verified to determine gestational day 0
(E0). Pregnant rats were then randomly divided into 2
groups: animals in the experimental group received intragas-
trically 100 mg of nitrofen dissolved in 1 mL of olive oil on
E9.5, whereas those in the control group received only the
vehicle. On E21 (preterm), the rats were sedated with
isofluorane and killed by intracardiac injection of potassium
chloride. The fetuses were recovered by cesarean delivery
and the diaphragm was carefully inspected for the presence
of CDH. The animal care committee approved all the animal
experiments (license number: 31-06).
1.1. Histochemistry
Whole mount preparations of CDH (n = 10) and control
(n = 10) tracheas were fixed in 4% paraformaldehyde
overnight and subsequently rinsed in phosphate buffered
saline (PBS). The tracheas were slit along the ventral
cartilaginous wall and histochemically stained for acetylcho-
linesterase (AChe) [11] (0.1 mol/L acetate buffer [pH 6.0],
6.5 mL; acetylthiocholine-iodide, 5.0 mg; 0.1 mol/L sodium
citrate, 0.46 mL; 30 mmol/L copper sulfate, 1.0 mL; distilled
water, 1.6 mL; 5 mmol/L potassium ferricyanide, 0.4 mL) for
1 hour at 37°C. The specimens were then mounted into a
Glycergel medium (DAKO, Glostrup, Denmark) and covered
by glass.
The intrinsic ganglia in the posterior membranous wall
of the tracheas were counted and their surface measured
with the assistance of an image analysis software (Image
Pro-Plus, version 5.0, Media Cybernetics, Washington,
DC). The total number of cartilaginous rings of each
trachea was divided into 3 parts to assign the ganglia to the
appropriate segment.
1.2. Immunohistochemistry
Cervico-thoracic blocks of CDH (n = 10) and control (n =
10) fetuses were fixed in 10% buffered formalin and then
embedded in paraffin. Transverse 5-μm-thick sections
perpendicular to the tracheal axis from the proximal and
distal parts of the organ were prepared, mounted on glass
slides, and allowed to dry. They were then deparaffinized,
unmasked, and peroxidase blocked before applying the
primary antibody. The slides were incubated with anti–low-
affinity neurotrophin receptor p75NTR (1:100; rabbit poly-
clonal p75NTR; Upstate, Lake Placid, NY) and anti-protein
gene product 9.5 (1:200; rabbit polyclonal PGP 9.5; Dako
Cytomation, Glostrup, Denmark) antibodies overnight at
4°C. Antibodies were labeled with the biotinylated strepta-
vidin-biotin method and visualized with diaminobenzidine.
Slides were then lightly counterstained with hematoxylin
before being dehydrated, cleared, and mounted.
The total surface of the sectioned organ (excluding the
mucosa) and the surface of submucosal and adventitial
immunostained neural tissue (ganglia + fibers) were
measured at both levels in 2 to 3 low-power fields with the
assistance of the image processing software. The areas to be
measured were contoured on the PC screen with the cursor
and the resulting surface was integrated by the software. The
proportion of the total surface occupied by immunostained
neural tissue was determined.
1.3. Immunoblotting
For immunoblotting, the membranous walls of the
tracheas from normal and nitrofen-exposed fetuses were
pooled (5 or more) and homogenized in the lysis buffer
(1 mmol/L sodium vanadate; 1% sodium dodecyl sulfate;
0.01 mol/L Tris-HCl, pH 7.4) with protease inhibitors. The
protein content was assessed using a protein assay kit (BCA
Protein Assay Kit, Pierce, Rockford, USA). The electro-
phoresis of 20 μg of total tracheal protein in an 18% sodium
dodecyl sulfate–polyacrylamide gel was performed, and the
separated proteins were electroblotted to a poly(vinylidene
fluoride) membrane (Bio-Rad, Hercules, CA, USA). After
blocking, the membrane was incubated overnight with anti-
PGP 9.5 (1:6000; rabbit polyclonal PGP 9.5; Dako
Cytomation) antibody at 4°C; it was then washed with
Tween-Tris-NaCl buffer and incubated with a horseradish
peroxidase–conjugated polyclonal antibody at 1:10,000
dilution for 1 hour at room temperature. The immunocom-
plexes were detected using an enhanced horseradish
peroxidase/luminol chemiluminescence (ECL Advance, GE
Healthcare, Little Chalfont Buckinghamshire, UK) and
subjected to autoradiography. The immunoblot bands were
quantified with the NIH Image V1.56 software. Superoxide
dismutase (SOD) expression from the same membrane
(polyclonal antibody anti-Cu/Zn SOD [1:2000]) was used
to correct the PGP 9.5 expression.
1.4. Messenger RNA isolation and quantitative
real-time reverse transcriptase–polymerase
chain reaction
The membranous walls of the tracheas were pooled (5 or
more) and frozen at −80°C. Total RNA was extracted using
an RNA extraction kit (Qiagen, Hilden, Germany), according
to the recommended protocol. The RNA strand (0.5 μg) was
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reverse transcribed into cDNA using a first strand cDNA
synthesis kit for reverse transcriptase–polymerase chain
reaction (RT-PCR; Roche, Manheim, Germany). Relative
levels of gene expression were measured by RT-PCR, using
LightCycler Fast Start DNA Master SYBR Green I kit
(Roche, Spain) and the LightCycler detector. The values of
PGP 9.5 were expressed after normalization by the levels of
s26 ribosomal protein used as housekeeping. The specific
primer sets used were as follows:
S26: Forward, 5′-AATTCGCTGCACGAACTGGC-3′; reverse,
5′-CAGCGCCAGCAGGTCTGAAT-3′
PGP 9.5: Forward, 5′-AGTGGCTCTCTGCAAAGCAG -3′;
reverse, 5′-GGCAGTAGAACGCAAGAAGA -3′
1.5. Statistical methods
The results were expressed as percentages or as means ±
SD, and both groups were compared by either 2-way
ANOVA or nonparametric Mann-Whitney tests as appro-
priate with a threshold of significance at P b .05.
2. Results
2.1. Histochemistry
An AChe-positive neural network was present in both
groups. In control tracheas, the nerve fibers were inter-
connected to form plexuses containing ganglia that ran in the
membranous wall and sent nerve bundles laterally between
the cartilaginous rings, as described in adult rat trachea [12].
The neural network was denser in the distal part of the
trachea. In CDH tracheas, this network was sparser and the
nerve trunks thinner than in control ones (Fig. 1).
The surface of the ganglia was significantly smaller in
CDH fetuses at all levels as depicted in Table 1, whereas the
number of ganglia was similar in both groups at both levels.
2.2. Immunohistochemistry
Tracheal neural cells stained positively for p75NTR in both
groups, confirming their neural crest origin.
The relative surface of PGP 9.5–immunostained neural
tissue (fibers + ganglia) over the total surface of the trachea
was significantly reduced in the distal part of tracheas from
CDH fetuses. Upon separate assessment of submucosal and
adventitial peritracheal neural structures, it turned out that the
difference was caused by a significant reduction of the
amount of neural tissue in the peritracheal plexus as shown
in Table 2.
2.3. Immunoblotting and quantitative
real-time RT-PCR
The signals for PGP 9.5 were seen at approximately 20 to
25 kd, and the protein levels were significantly lower in the
Fig. 1 Whole mount preparations of control (A) and CDH (B) tracheas stained for AChe. The cartilaginous rings are visible on each side of
the posterior membranous wall. In controls, the nerve fibers are interconnected to form plexuses containing ganglia. These fibers run in the
posterior membranous wall and send nerve bundles laterally between the cartilaginous rings (A). The neural network is clearly sparser in rats
with CDH and the ganglia are smaller than in controls (B).
Table 1 Surface of ganglia in whole mount preparations of the trachea (AChe staining)
Control (n = 10) CDH (n = 10)
Proximal Distal Proximal Distal
Surface of ganglia (μm2) 3579 ± 4154 4927 ± 5607 1688 ± 1896 ⁎ 3426 ± 3726 ⁎
Values are shown as means ± SD.
⁎ P b .05 vs control.
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tracheas from CDH fetuses compared to the control group
(Fig. 2).
In contrast, PGP 9.5 mRNA expression was signifi-
cantly increased in CDH tracheas in comparison with
controls (Fig. 3).
3. Discussion
Survivors of CDH have long-term pulmonary morbidity
owing to the pulmonary hypoplasia and barotrauma from
mechanical ventilation. However, frequent respiratory tract
infections, obstructive airway pattern, and increased reactive
airway disease [1-3,13,14] were also seen in survivors with
mild to moderate pulmonary hypoplasia, suggesting that
other causes might be involved. Malformations of the
tracheobronchial tree were described both in the experi-
mental model of CDH [15] and in patients with CDH [16].
Abnormal motility of the tracheobronchial tree is also present
in rats with experimental CDH [7].
The human lung develops as an endodermal foregut
outgrowth destined to become the trachea; it elongates,
invading the surrounding mesenchyme, and continues to
branch until the bronchial tree is formed [17,18]. From the
early stages of lung development, the airway smooth muscle
covers the branching epithelial tubules destined to become
the future bronchial tree and the smooth muscle layer is
ensheathed in a network of nerves and ganglia [19-21]. It has
been suggested that airway smooth muscle may function as a
mechanical prerequisite for lung growth by generating a
positive pressure in the liquid-filled tubules which is
necessary for normal lung growth; the reduction of this
pressure by draining of the liquid contents causes lung
hypoplasia [22], whereas its increase by tracheal occlusion
enhances lung growth [23,24]. Tracheobronchial innervation
controls smooth muscle tension and also regulates secretion
by the submucosal glands, epithelial cell function, bronchial
vascular tone, and tracheobronchial reflexes [25,26]. As the
airway smooth muscle has an important role in lung
development, we speculated that an impaired control of the
tracheobronchial motility might partially account for pul-
monary hypoplasia.
The neural crest supplies tracheobronchial innervation
through the vagus nerves [8,27]. These and the intrinsic
esophageal innervation are deficient both in babies and in rat
fetuses with CDH [10].
Staining with anti-p75NTR antibody confirmed that
tracheal neural cells are, like those of the gastrointestinal
Table 2 Neural surface in transversal sections of the trachea
Marker Surface measured Control (n = 10) CDH (n = 10)
Proximal Distal Proximal Distal
PGP 9.5 Neural/overall surface (%) 1.19 ± 0.31 2.07 ± 0.94 1.03 ± 0.47 1.36 ± 0.51 ⁎
Peritracheal neural/overall surface (%) 0.61 ± 0.30 1.33 ± 0.57 0.55 ± 0.36 0.70 ± 0.35 ⁎
Values are shown as means ± SD.
⁎ P b .05 vs control.
Fig. 2 PGP 9.5 protein level normalized to SOD in both groups
(control + CDH). Anti–PGP 9.5 antibody hybridized with a single
band between 20 and 25 kd. The expression of PGP 9.5 was
significantly decreased in the CDH group (#P b .05 vs control).
Fig. 3 PGP 9.5 mRNA expression level in each group of tracheas
(control + CDH). The expression of PGP 9.5 was significantly
increased in the CDH group (#P b .05 vs control).
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tract, neural crest derived. The antiserum against PGP 9.5 has
been used in immunostaining as a pan-neuronal marker of
the peripheral nervous system, staining fibers, and ganglia.
The ganglionic precursors can be distinguished with anti–
PGP 9.5 since the early phase of development. The tracheal
neural tissue was clearly deficient in CDH fetuses in terms of
decreased surface of the ganglia (AChe) in the posterior wall
and density of neural structures (PGP 9.5) in the peritracheal
plexus of the distal half of the trachea. In addition, PGP 9.5–
protein levels were decreased in the tracheas of fetuses with
CDH. In contrast, PGP 9.5–mRNA expression was
increased in them.
PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase
isozyme L1 [28] and is expressed in neurons and nerve
fibers at all levels of the central and peripheral nervous
system and in neuroendocrine tissue [29]. Ubiquitin is
involved in protein degradation and the hydrolases regener-
ate ubiquitin from ubiquitin/protein complexes targeted for
degradation. Different studies demonstrated both in rat [30]
and in mouse [31] that there is a parallel distribution of PGP
9.5 protein and PGP 9.5 mRNA, although the correlation is
not quantitatively absolute. PGP 9.5 is present in both motor
and sensory neuronal precursors during their development
and also in the differentiated neurons, suggesting a
significant role for the ubiquitin hydrolases throughout the
differentiation of these cells.
In our study, the PGP 9.5 mRNA transcripts were
increased in the tracheas of fetuses with CDH in comparison
with the controls, suggesting that posttranslational events
occur in the development of CDH tracheas and may play a
role in the impairment of the expression.
The present study is the first to demonstrate deficient
tracheal innervation in the experimental model of CDH. The
motor counterparts of these deficits are being currently
investigated. If similar anomalies are present in babies with
CDH, they might participate in the pathogenesis of lung
hypoplasia and/or bronchopulmonary sequelae. Unfortu-
nately, tracheal innervation could not be examined in babies
with CDH because the standard techniques of neonatal
autopsies do not allow appropriate harvesting of tracheal
material for studies of this nature. Prospective collection of
specimens suitable for complete studies of tracheal innerva-
tion is highly desirable.
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Abstract
Background We previously demonstrated that tracheo-
bronchial innervation, originated from the vagus nerve and
hence of neural crest origin, is deficient in rats with
experimental congenital diaphragmatic hernia (CDH). The
present study examines the development of this innervation
during fetal life in an attempt to understand the nature of
these deficiencies.
Materials and methods Pregnant rats were given either
100 mg nitrofen or vehicle on E9.5. Embryos were recov-
ered on E15 and E18. Control and nitrofen/CDH pups
(n = 10 each) were studied on each of these days and
compared with our previous results on E21. Whole mount
preparations of tracheas stained for anti-protein gene prod-
uct 9.5 (PGP 9.5) and smooth muscle contractile a-actin
were examined under confocal microscopy for the mor-
phology of intrinsic neural network. Sections of tracheas
were immunostained with anti-low-affinity neurotrophin
receptor (p75NTR), neural cell marker PGP 9.5, and anti-glial
cell marker S100 antibodies. The proportions of sectional
areas occupied by neural and glial structures were measured
in the proximal and distal trachea. PGP 9.5 protein, and
mRNA expressions were determined. Mann–Whitney tests
with a threshold of significance of P\ 0.05 were used for
comparison.
Results Positive staining for p75NTR confirmed the neural
crest origin of tracheal neural cells. The neural network
appeared less organized on E15, and it was less dense on
E18 in nitrofen-exposed embryos than in controls. The
proportions of section surface occupied by neural elements
were similar in both groups on E15, but that of glial tissue
was significantly increased in nitrofen-exposed embryos.
On E18, the relative neural surface was significantly
reduced in CDH embryos in contrast with increased glial
tissue surface. On E21 the proportion of neural tissue was
reduced only in the distal trachea. The expression of PGP
9.5 protein was decreased in CDH fetuses on E18 and E21.
In contrast, PGP 9.5 mRNA levels were increased in CDH
fetuses on E18 and E21.
Conclusions The development of intrinsic innervation of
the trachea in rats with CDH is abnormal with reduction of
neural tissue accompanied by increase of glial tissue that
could represent a response to neural damage. The signifi-
cance of increased PGP 9.5 mRNA levels is unclear.
Keywords Diaphragmatic hernia  Intrinsic innervation 
Trachea  Nitrofen  Neural crest  Lung p75NTR 
PGP 9.5  S100
Introduction
Long-term pulmonary morbidity occurs often in survivors
of congenital diaphragmatic hernia (CDH) as sequela of
pulmonary hypoplasia and barotrauma due to mechanical
ventilation. Since tracheobronchial peristalsis plays a sig-
nificant role in lung morphogenesis [1, 2], we hypothesized
that abnormal tracheobronchial innervation might account
in part for these symptoms. In our previous study on E21
(near-term) rats we found deficient tracheal neural tissue in
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CDH fetuses in terms of decreased surface of ganglia and
density of neural structures as well as abnormal expression
of PGP 9.5 protein and levels of PGP 9.5 mRNA [3].
The present study addressed the development of tracheal
innervation in the embryo–fetal period and tested the
hypothesis that the abnormalities described in rat pups with
CDH on E21 might be the result of either delayed devel-
opment of innervation or of neural damage and repair.
Materials and methods
Adult Sprague–Dawley female rats were mated overnight.
The finding of spermatozoids in the vaginal smear deter-
mined gestational day 0 (E0). Pregnant rats were then
randomly divided into four groups: control E15, nitrofen
E15, control E18 and CDH E18. Animals in the experi-
mental group received intragastrically 100 mg of nitrofen
dissolved in 1 ml of olive on E9.5, whereas those in the
control group received only vehicle. On E15 and E18, the
rats were sedated with isofluorane and killed by intracar-
diac injection of potassium-chloride. The embryos and
fetuses were recovered and on E18 the diaphragm was
inspected for the presence of CDH. On E15 all the embryos
were used and randomly allocated to the different tech-
niques. The Animal Care Committee approved all the
animal experiments (license number: 31–06).
Immunohistochemistry
Whole mount preparations of all groups were fixed in 4%
paraformaldehyde overnight and subsequently rinsed in
phosphate buffered saline (PBS). Nonspecific binding was
blocked by washing them in PBS with 1% bovine-serum
albumin, before incubating the tracheas with the primary
antibodies overnight. A rabbit polyclonal antibody against
protein gene product 9.5 (PGP 9.5; 1:500; Dako Cytoma-
tion, Glostrup, Denmark) was used to stain the neural
tissue, whereas the smooth muscle was identified with a
mouse monoclonal anti-a-actin fluorochrome-labeled anti-
body (anti-actin, a-smooth muscle-Cy3TM antibody;
1:1000: Sigma–Aldrich, St. Luis, MO). After washing with
PBS, the samples were incubated at room temperature for
1 h with the fluorochrome-labeled anti-rabbit secondary
antibody (Alexa FluorÒ 488; 1:500; Molecular Probes,
Eugene, OR). After further washing with PBS, the speci-
mens were then mounted into glycerol on a glass slide. As
a control the primary antibody was omitted with no stain-
ing above background as a result.
Fluorescent images of the nerves and smooth muscle in
the double-stained whole mount preparations were
obtained using a confocal laser scanning microscope (Leica
TCS SP5) with LAS-AF software. The fluorescent markers
were detected by a kripton/argon laser with excitation
wavelengths of 488 nm for Alexa 488 and 561 nm for Cy3.
The whole mounts were optically sectioned by scanning at
increasing depths of focus in steps of 5 lm. After double
staining, the green and the red images were captured sep-
arately, colorized and merged to show a composite nerve/
smooth muscle image. The pattern of the neural network in
the posterior membranous wall of the tracheas was com-
pared between nitrofen/CDH and controls.
To measure the relative surface covered by neural tissue
and glial cells, cervico-thoracic blocks of embryos and
fetuses were fixed in 10% buffered formalin and then
embedded in paraffin. Transversal 5 lm sections perpen-
dicular to the tracheal axis from the proximal and distal
parts of the organ were prepared, mounted on glass slides
and allowed to dry. They were then deparaffinized,
unmasked and peroxidase-blocked before applying the
primary antibody. The slides were incubated with anti-low-
affinity neurotrophin receptor p75NTR (1:100; rabbit poly-
clonal p75NTR; Upstate, Lake Placid, NY), anti-protein
gene product 9.5 (1:200; rabbit polyclonal PGP 9.5; Dako
Cytomation, Glostrup, Denmark) and anti-glial cell marker
S100 (1:2000; rabbit polyclonal S100; Dako Cytomation,
Glostrup, Denmark) antibodies overnight at 4°C. Anti-
bodies were labeled with biotinylated streptavidin-biotin
method and visualized with diaminobenzidine. Slides were
then lightly counter-stained with hematoxylin before being
dehydrated, cleared and mounted.
The total surface of the sectioned organ (excluding the
mucosa) and the surface of immunostained neural (gan-
glia ? fibers) and glial tissue were measured at both levels
in 1–2 low-power fields with the assistance of image pro-
cessing software (Image Pro-PlusTM, version 5.0, Media
Cybernetics, Washington, DC, USA). The areas to be
measured were contoured on the PC screen with the cursor
and the resulting surface was integrated by the software.
The proportion of the total surface occupied by immuno-
stained neural tissue and glial cells was determined.
Immunoblotting
Tracheas from the four groups were pooled (eight or more)
and homogenized in lysis buffer (1 mmol/l sodium vana-
date; 1% SDS; 0.01 mol/l Tris–HCl, pH 7.4) with protease
inhibitors. The protein content was assessed using a protein
assay kit (BCA Protein Assay Kit, Pierce). 20 lg of total
tracheal protein was separated by 18% SDS-polyacryl-
amide gel electrophoresis and the separated proteins were
electroblotted to a PVDF membrane (Bio-Rad). The
membrane was blocked and then incubated overnight with
anti-PGP 9.5 (1:6000; rabbit polyclonal PGP 9.5; Dako
Cytomation, Glostrup, Denmark) antibody at 4°C; it was
then rinsed in Tween-Tris–NaCl buffer and incubated with
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a horseradish peroxidase-conjugated polyclonal antibody at
1:10000 dilution for 1 h at room temperature. The antigen–
antibody complexes were detected using an enhanced
horseradish peroxidase/luminol chemiluminescence kit
(ECL advance GE Healthcare, UK) and subjected to
autoradiography. The immunoblot bands were quantified
with NIH Image V1.56 software. The normalization was
done using super-oxide-dysmutase (SOD).
mRNA isolation and quantitative real time RT-PCR
The membranous walls of tracheas were pooled (eight or
more) and frozen at -80°C. Total RNA was extracted
using a RNA extraction kit (Qiagen, Spain), according to
recommended protocol. The RNA strand (0.5 lg) was
reverse-transcribed into cDNA using first strand cDNA
synthesis kit for RT-PCR (Roche, Spain). Relative levels of
gene expression were measured by RT-PCR, using Light-
cycler Fast Start DNA Master SYBR Green I kit (Roche,
Spain) and lighcycler detector. PGP 9.5 values were nor-
malized to the levels of s26 ribosomal protein used as
housekeeping. The specific primer sets used were as
follows:
S26 PGP 9.5
Forward 50-AATTCGCTGC
ACGAACTGGC-30
Forward 50-AGTGGCTCTCTG
CAAAGCAG-30
Reverse 50-CAGCGCCAGCA
GGTCTGAAT-30
Reverse 50-GGCAGTAGAA
CGCAAGAAGA-30
Statistical methods
The results were expressed as percentages or as
mean ± SD and both groups were compared by either two-
way ANOVA or non-parametric Mann–Whitney tests as
appropriate with a threshold of significance at P\ 0.05.
Results
Immunohistochemistry
In both control groups (E15 and E18) the posterior mem-
branous wall of the trachea contained smooth muscle
ensheated in a plexus of nerve fibers with ganglia that sent
nerve bundles laterally between the cartilaginous rings, as
described in our previous study of the rat trachea on E21 [3].
On E15 the nerve fibers of the membranous wall of the
tracheas were poorly interconnected in the nitrofen group
(Fig. 1) whereas the neural network was better developed,
although sparser, on E18 CDH (Fig. 2).
Tracheal neural cells stained positively for p75NTR in all
groups, confirming their neural crest origin.
On E15, the relative surface of glial cells (immuno-
stained for S100) over the total surface of the trachea was
significantly increased in embryos exposed to nitrofen both
at the proximal and distal levels (Table 1). In contrast, no
differences were found comparing the relative surface of
neural tissue (fibers ? ganglia) immunostained for PGP
9.5 in nitrofen and control groups.
On E18, the proportion of section surface occupied by
neural elements was significantly reduced in the tracheas
from CDH fetuses (Fig. 3), while that of glial cells was
significantly increased in the same group at both levels
(Fig. 4), as shown in Table 2.
Immunoblotting and quantitative real time RT-PCR
The signals for PGP 9.5 were seen at approximately
20–25 kD. On E18, the protein levels were significantly
Fig. 1 Confocal projection of
control (a) and nitrofen (b)
tracheas of E15 embryos.
Bundles of a-actin-positive
muscle fibers (red) cover the
posterior wall of the tracheas in
both groups. In control
embryos, PGP 9.5
immunoreactivity (green)
reveals interconnected nerve
fibers that form plexuses
containing ganglia. These fibers
are poorly interconnected in
embryos exposed to nitrofen (b)
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lower in the tracheas from CDH fetuses compared to
control group (Fig. 5).
In contrast, PGP 9.5 mRNA expression was significantly
increased in CDH tracheas in comparison with controls
(Fig. 6).
On E15 the findings resembled those seen on E18 with
lower PGP 9.5 protein levels and increased PGP 9.5 mRNA
expression in nitrofen tracheas, but the differences were not
significant.
Looking at the expression of the protein over the
development, we found that PGP 9.5-protein levels
increased significantly in control tracheas between E15 and
E18 and tended to decrease between E18 and E21. In
contrast, the protein expression did not change between
Fig. 2 Confocal projection of
control (a) and nitrofen (b)
tracheas of E18 fetuses. In both
groups airway smooth muscle
(red) covers the posterior wall
of the trachea. In control
fetuses, the fibers (green),
running in the posterior wall,
form dense plexuses with
ganglia (a). The network is
sparser in fetuses with CDH (b)
Table 1 Glial cell surface in transversal sections of the trachea on E15 (means ± SD)
Marker Surface measured Control (n = 10) CDH (n = 10)
Proximal Distal Proximal Distal
PGP 9.5 Neural/overall surface (%) 1.58 ± 1.11 2.48 ± 1.09 0.96 ± 1.01 1.91 ± 1.11
S 100 Glial cell/overall surface (%) 0.05 ± 0.06 0.09 ± 0.04 0.23 ± 0.12 * 0.20 ± 0.07 *
* P\ 0.05 versus control
Fig. 3 Transversal sections of
tracheas of control (a) and CDH
(b) E18 fetuses immunostained
for PGP 9.5. In control fetuses, a
dense network of fibers (arrows)
is present both in submucosal
and peritracheal plexuses (a). In
contrast, the neural network
(arrows) is markly reduced in
CDH fetuses (b). Notice the
smaller size and the abnormal
contour of the trachea in this
group
Fig. 4 Transversal sections of
tracheas of control (a) and CDH
(b) E18 fetuses immunostained
for S100. In CDH trachea (b)
glial tissue (arrowheads) is
increased in comparison with
the control group (a;
arrowheads)
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E15 and E18 in embryos and fetuses exposed to nitrofen
and it was mildly reduced between E18 and E21. The PGP
9.5 mRNA expression was decreased over the development
in the control groups; in contrast, there was a mild incre-
ment between E15 and E18 followed by a significant
reduction over the last part of the gestation in nitrofen and
CDH groups.
Discussion
Survivors of CDHhave long-term pulmonary sequelae [4–6]
mainly due to the pulmonary hypoplasia and barotrauma
from mechanical ventilation but likely for other causes as
well. Since the airway smooth muscle has an important role
in lung development [1, 2], we speculated that impaired
control of the tracheobronchial motility might account in
part for pulmonary hypoplasia and that innervation of the
airway smooth muscle, which has a crucial role in lung
development [7, 8] could be abnormal in CDH. This muscle
encircles the growing epithelial bronchi and provides tone to
maintain the lung fluid at a positive pressure that stimulates
lung growth by inducing growth factor production and cell
proliferation [9–11]. The origin of this innervation is the
neural crest which cells reach the developing trachebron-
chial tree from the vagus nerves [12]. The neural tissue
ensheates the airways and sends bundles to the smooth
muscle [13, 14].
In a previous study we described deficiencies of neural
tissue in the tracheas of E21 (near-term) rats with CDH [3]:
the density of neural tissue and the surface of ganglia were
decreased as well as the expression of PGP 9.5 protein; in
contrast, the levels of PGP 9.5 mRNA were increased.
These findings suggested that delayed development and/or
neural damage could account for deficient innervation.
In the present study we tested the first of these
hypotheses by examining the development of tracheal
neural tissue in control and nitrofen-exposed embryos and
fetuses. PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase
isozyme L1 [15] expressed at all levels of the central and
peripheral nervous system [16] in neurons and nerve fibers
as well as in the neuronal precursors over the development,
suggesting a role in the development and differentiation of
these cells. With this staining we confirmed the patterns
of innervation previously described in the upper airways of
human [8] and normal mouse [7, 17] and showed that in
Table 2 Neural and glial cell surfaces in transversal sections of the trachea on E18 (mean ± SD)
Marker Surface measured Control (n = 10) CDH (n = 10)
Proximal Distal Proximal Distal
PGP 9.5 Neural/overall surface (%) 1.38 ± 0.53 3.11 ± 1.79 0.82 ± 0.63 * 1.41 ± 1.14 *
S 100 Glial cell/overall surface (%) 0.12 ± 0.06 0.15 ± 0.06 0.65 ± 0.27 * 0.96 ± 0.45 *
* P\ 0.05 versus control
Fig. 5 PGP 9.5 protein level normalized to super-oxide-dysmutase
(SOD) in all endpoints (E21 from our previous study [3]). Anti-PGP
9.5 antibody hybridized with a single band between 20 and 25 kD.
The expression of PGP 9.5 is significantly decreased on E18 and E21
in CDH fetuses (#P\ 0.05 vs. control). The reduction on E15
nitrofen-exposed embryos is not significant
Fig. 6 PGP 9.5 mRNA expression level in all groups (E21 from our
previous study [3]). It is significantly increased on E18 in fetuses with
CDH (#P\ 0.05 vs. control), whereas the difference on E15 is not
significant
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fetuses with CDH, the neural interconnections were poor in
the tracheas on E15 and clearly sparser on E18 and E21.
PGP 9.5 protein levels increased significantly in control
tracheas between E15 and E18 but remained unchanged in
those from embryos and fetuses exposed to nitrofen. The
PGP 9.5 mRNA expression progressively declined in
controls during the period studied and it also did so in
nitrofen-exposed fetuses but starting from higher levels.
This pattern is consistent with the hypothesis of a
delayed development in animals with CDH in which tra-
cheal innervation seems immature on E15, and deficient
thereafter. On the other hand, increased PGP 9.5 mRNA
transcripts in this group suggest post-translational events
that could play a role in this impaired expression.
To test the hypothesis of a neural damage in the course
of the development we used S100, a calcium-binding
protein expressed in glial cells and also in Schwann cells
[18, 19]. Its increased expression has been interpreted as a
compensatory mechanism for defective neural tissue [20]
and S100B mRNA levels have been used as a marker for
brain injury [21, 22]. We found significantly increased
population of glial cells in nitrofen-exposed embryos on
E15 and in CDH fetuses on E18. This increment of glial
tissue in CDH fetuses associated with scanty neural
structures may be interpreted as a response to neural
damage and compensation for the defective neuronal
tissue.
The present study, which is the first to address the
development of tracheal innervation in the experimental
model of CDH, demonstrates that the deficits of tracheal
innervation are the consequence of abnormal development
in terms of delay and neural damage. Equivalent abnor-
malities in babies with CDH might contribute to the
pathogenesis of lung hypoplasia and/or bronchopulmonary
sequelae.
Acknowledgments This work was supported in part by FIS (06/0486
and 06/0447), FIHULP and FMM Grants.
References
1. Jesudason EC, Smith NP, Connell MG et al (2006) Peristalsis of
airway smooth muscle is developmentally regulated and uncou-
pled from hypoplastic lung growth. Am J Physiol Lung Cell Mol
Physiol 291:L559–L565
2. Jesudason EC (2006) Small lungs and suspect smooth muscle:
congenital diaphragmatic hernia and the smooth muscle hypoth-
esis. J Pediatr Surg 41:431–435
3. Pederiva F, Aras Lopez R, Martinez L, Tovar JA (2009) Tracheal
innervation is abnormal in rats with experimental congenital
diaphragmatic hernia. J Pediatr Surg (in press)
4. Trachsel D, Selvadurai H, Bohn D et al (2005) Long-term pul-
monary morbidity in survivors of congenital diaphragmatic
hernia. Pediatr Pulmonol 39:433–439
5. Muratore CS, Kharasch V, Lund DP et al (2001) Pulmonary
morbidity in 100 survivors of congenital diaphragmatic hernia
monitored in a multidisciplinary clinic. J Pediatr Surg 36:133–
140
6. Kamata S, Usui N, Kamiyama M et al (2005) Long-term follow-
up of patients with high-risk congenital diaphragmatic hernia.
J Pediatr Surg 40:1833–1838
7. Tollet J, Everett AW, Sparrow MP (2001) Spatial and temporal
distribution of nerves, ganglia, and smooth muscle during the
early pseudoglandular stage of fetal mouse lung development.
Dev Dyn 221:48–60
8. Sparrow MP, Weichselbaum M, McCray PB (1999) Development
of the innervation and airway smooth muscle in human fetal lung.
Am J Respir Cell Mol Biol 20:550–560
9. Sparrow MP, Warwick SP, Mitchell HW (1994) Foetal airway
motor tone in prenatal lung development of the pig. Eur Respir J
7:1416–1424
10. Sparrow MP, Warwick SP, Everett AW (1995) Innervation and
function of the distal airways in the developing bronchial tree of
fetal pig lung. Am J Respir Cell Mol Biol 13:518–525
11. Cilley RE, Zgleszewski SE, Chinoy MR (2000) Fetal lung
development: airway pressure enhances the expression of
developmental genes. J Pediatr Surg 35:113–118 discussion 119
12. Burns AJ, Delalande JM (2005) Neural crest cell origin for
intrinsic ganglia of the developing chicken lung. Dev Biol
277:63–79
13. Weichselbaum M, Everett AW, Sparrow MP (1996) Mapping the
innervation of the bronchial tree in fetal and postnatal pig lung
using antibodies to PGP 9.5 and SV2. Am J Respir Cell Mol Biol
15:703–710
14. Weichselbaum M, Sparrow MP (1999) A confocal microscopic
study of the formation of ganglia in the airways of fetal pig lung.
Am J Respir Cell Mol Biol 21:607–620
15. Wilkinson KD, Lee KM, Deshpande S et al (1989) The neuron-
specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydro-
lase. Science 246:670–673
16. Wilson PO, Barber PC, Hamid QA et al (1988) The immunolo-
calization of protein gene product 9.5 using rabbit polyclonal and
mouse monoclonal antibodies. Br J Exp Pathol 69:91–104
17. Tollet J, Everett AW, Sparrow MP (2002) Development of neural
tissue and airway smooth muscle in fetal mouse lung explants: a
role for glial-derived neurotrophic factor in lung innervation. Am
J Respir Cell Mol Biol 26:420–429
18. Stefansson K, Wollmann RL, Moore BW (1982) Distribution of
S-100 protein outside the central nervous system. Brain Res
234:309–317
19. Sheppard MN, Kurian SS, Henzen-Logmans SC et al (1983)
Neurone-specific enolase and S-100: new markers for delineating
the innervation of the respiratory tract in man and other mam-
mals. Thorax 38:333–340
20. Boleken M, Demirbilek S, Kirimiloglu H et al (2007) Reduced
neuronal innervation in the distal end of the proximal esophageal
atretic segment in cases of esophageal atresia with distal tra-
cheoesophageal fistula. World J Surg 31:1512–1517
21. Goncalves CA, Leite MC, Nardin P (2008) Biological and
methodological features of the measurement of S100B, a putative
marker of brain injury. Clin Biochem 41:755–763
22. Kochanek PM, Berger RP, Bayir H et al (2008) Biomarkers of
primary and evolving damage in traumatic and ischemic brain
injury: diagnosis, prognosis, probing mechanisms, and thera-
peutic decision making. Curr Opin Crit Care 14:135–141
1346 Pediatr Surg Int (2008) 24:1341–1346
123
     PAPER III 
 
37 
 
 
 
 
BRONCHOPULMONARY INNERVATION DEFECTS IN INFANTS AND RATS WITH 
CONGENITAL DIAPHRAGMATIC HERNIA. 
 
Pederiva F, Lopez RA, Rodriguez JI, Martinez L, Tovar JA. 
 
J Pediatr Surg 2010;45:360-5. 
 
Bronchopulmonary innervation defects in infants and rats
with congenital diaphragmatic hernia☆,☆☆
Federica Pederivaa, Rosa Aras Lopeza, Jose I. Rodriguezb,
Leopoldo Martineza, Juan A. Tovar a,⁎
aDepartment of Pediatric Surgery and Research Laboratory, Hospital Universitario La Paz, 28046 Madrid, Spain
bDepartment of Pathology, Hospital Universitario La Paz, 28046 Madrid, Spain
Received 21 October 2009; accepted 27 October 2009
Key words:
Diaphragmatic hernia;
Intrinsic innervation;
Nitrofen;
Neural crest;
Lung
Abstract
Introduction: Pulmonary morbidity in survivors of congenital diaphragmatic hernia (CDH) is caused by
hypoplasia, barotraumas, or other reasons. We have previously shown deficient tracheal innervation in
rats with CDH. Now we examine whether bronchopulmonary innervation is also abnormal in both
infants and rats with CDH.
Material and Methods: Sections of E15, E18, and E21 rat lungs were immunostained for Protein gene
product 9.5 and S100 antibodies. Similar immunostaining was performed on tissue from infants dying
from CDH (n = 6) and other causes (n = 6) with Neurofilament, S100, and Rearranged during
transfection antibodies. Nerve trunks/bronchus were counted, and the proportion of glial and RET-
positive cells/bronchial surface was calculated. Glial cell-line derived neurotrophic factor protein and
mRNA were measured in rat lungs.
Results: Nerve trunks/bronchus were decreased in infants and rat fetuses with CDH. In contrast, glial and
RET-positive cells/bronchial surface were increased in infants and rats with CDH. Both lungs were equally
affected. GDNF protein was high, whereas GDNF mRNA was decreased in preterm animals with CDH.
Conclusions: The lungs of infants and rats with CDH have decreased neural components compensated
by increased supporting glial cells and persistence high expression of RET and GDNF protein.
Because bronchopulmonary innervation controls airway smooth muscle, vessels, and glandular
secretions, it is tempting to hypothesize that these deficiencies might play a role in respiratory
morbidity in CDH.
© 2010 Elsevier Inc. All rights reserved.
Pulmonary hypoplasia persisting beyond infancy [1,2]
and lung injury caused by mechanical ventilation [3] are
major determinants of respiratory morbidity in survivors of
congenital diaphragmatic hernia (CDH). These factors
contribute to obstructive and restrictive pulmonary disease
described in CDH survivors [3-5]. However, increased
incidence of respiratory infections, bronchial obstruction,
wheezing, asthma, and bronchial hyperreactivity has been
found also in survivors with mild pulmonary hypoplasia [6],
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suggesting that other causes might be involved. We
demonstrated previously that tracheal innervation is abnor-
mal in rats with CDH [7,8] and concluded that, if similar
anomalies were found in human CDH, this deficiency could
play a role in chronic lung disease of survivors. We felt that
the next step would be to examine bronchopulmonary
innervation, and the current study tests the hypotheses that
bronchopulmonary innervation might be abnormal in
infants dying of CDH and also in rat fetuses with
experimental CDH.
1. Materials and methods
Adult Sprague-Dawley female rats were mated overnight,
and the presence of spermatozoids in the vaginal smear
determined gestational day 0 (E0). Pregnant rats received
intragastrically 100 mg of nitrofen dissolved in 1 mL of olive
or only vehicle on E9.5. The embryos and fetuses were
recovered by cesarean section on E15, E18, and E21. The
diaphragm was inspected for the presence of CDH on E18
and E21, and only rats with the malformation were further
processed. Because of size restrictions, all E15 embryos were
processed. The Animal Care Committee approved the animal
experiments (license number: 31-06). Paraffin blocks of the
lungs from 6 newborns who had died of CDH and from 6
age-matched infants who died from other unrelated condi-
tions were investigated following institutional research board
approval. At least 3 bronchi of comparable size were
examined in each lung both in infants and in rat fetuses at
all endpoints.
1.1. Immunohistochemistry
Thoracic blocks of CDH (n = 10) and control (n = 10)
embryos and fetuses of each endpoint were fixed in 10%
buffered formalin and then embedded in paraffin. After the
staining protocol previously described [7], the slides were
incubated with anti–low-affinity neurotrophin receptor
p75NTR (1:100; rabbit polyclonal p75NTR; Upstate, Lake
Placid, NY), antiprotein gene product 9.5 (1:200; rabbit
polyclonal PGP 9.5; Dako Cytomation, Glostrup, Denmark),
and antiglial cell marker S100 (1:800; rabbit polyclonal
S100; Dako Cytomation) antibodies.
In a similar way, the human lung autopsy material was
stained with antineurofilament (1:800; rabbit polyclonal NF;
Dako Cytomation), antiglial cell marker S100 (1:600; rabbit
polyclonal S100; Dako Cytomation), and anti-RET (1:200;
rabbit polyclonal RET; Santa Cruz Biotechnology, Inc,
Spain) antibodies.
Nerve trunks per bronchus, either stained by PGP 9.5 or
NF, were counted. The proportion of glial supporting tissue
(S100) and RET-positive cells over the bronchial section
surface (excluding the mucosa) was calculated with the
assistance of image processing software.
1.2. Immunoblotting
Both lungs from normal and nitrofen-exposed fetuses of
each endpoint were pooled (3 or more) and underwent the
procedures previously described [7] for immunoblotting,
using a 15% sodium dodecyl sulfate polyacrylamide gel. The
membrane was incubated with antiglial cell line–derived
neurotrophic factor (1:10,000; rabbit polyclonal GDNF;
BioVision, Mountain View, CA) antibody, and the results
were normalized to superoxide dismutase (SOD; 1:2000;
polyclonal antibody anti–Cu/Zn SOD).
1.3. mRNA isolation and quantitative real-time
polymerase chain reaction
Total RNA from the lungs of 3 embryos and fetuses of each
endpoint was isolated with a RNA extraction kit (Qiagen,
Hilden, Germany, and Roche, Mannhein, Germany), and 1 μg
was reverse transcribed into cDNA using first-strand cDNA
synthesis kit for reverse transcriptase polymerase chain
reaction (Roche, Spain). The specific sequences of forward
and reverse primers (Bonsaitech, Spain) used were as follows;
GDNF GTTATGGGATGTCGTGGCTG (forward) and
CAGATAAACAAGCGGCGGCA (reverse). Each sample
was run in duplicate, and the mean value was used to calculate
mRNA expression. The quantity of GDNF in each sample was
calculated comparing the CT values of each endpoint with E15
control, used as calibrator (2−ΔΔCT). The cycle threshold (CT)
values of both calibrator and samples were normalized to the
endogenous housekeeping gene 18s.
1.4. Statistical methods
The results were expressed as percentages or as means ±
SD, and both groups were compared by either 2-way analysis
of variance or nonparametric Mann-Whitney tests as
appropriate, with a threshold of significance at P b .05.
2. Results
2.1. Immunohistochemistry
The neural crest origin of the lung neural cells was
confirmed by the positive staining for p75NTR in all groups.
Peribronchial nerve trunks were significantly reduced
in both lungs of infants with CDH (NF immunostaining;
Fig. 1A) and of rat embryos exposed to nitrofen and
fetuses with CDH (PGP 9.5 immunostaining; Fig. 2A) in
comparison with controls. Ipsilateral and contralateral
lungs were equally affected in both settings.
In contrast, the proportion of glial tissue surface over
bronchial section surface was significantly increased both
in infants with CDH (Figs. 1B and 3A [control] and B
361Bronchopulmonary innervation defects in infants with CDH
[CDH]) and in rats exposed to nitrofen (Figs. 2B and 3C
[control] and D [CDH]) without any difference between
both lungs. The proportion of RET-positive cells over the
bronchus surface was significantly increased in lungs of
infants with CDH (Fig. 1C).
2.2. Immunoblotting and quantitative real-time
reverse transcriptase polymerase chain reaction
The signals for GDNF were seen at 15 kD, and the protein
levels remained persistently high in all endpoints in animals
exposed to nitrofen (Fig. 4A).
GDNF mRNA transcripts that were increased on E15
were significantly decreased in E18 and E21 animals with
CDH (Fig. 4B).
3. Discussion
Persistent lung hypoplasia with structural abnormalities in
distal airways and barotrauma owing to neonatal intensive
care treatment have been repeatedly considered as possible
causes of long-term pulmonary sequelae in survivors of CDH
[3-5,9]. However, these children are prone to develop
pulmonary exacerbations secondary to viral respiratory
infections, they experience wheezing and symptoms of
airway hyperresponsiveness and asthma, and they have
abnormalities in pulmonary function including obstructive,
restrictive, or a combined ventilation impairment even when
the pulmonary hypoplasia is mild to moderate [5,6,10,11].
This suggests that also other causes might contribute to
pulmonary morbidity.
Fig. 1 A, The number of NF-positive nerve trunks per bronchus
in human lungs is decreased in both lungs of infants with CDH
(CDH R and L) in comparison with corresponding control lungs
(#P b .05 versus control). B, The proportion of S100-stained glial
tissue/bronchus section in human lungs is increased in both lungs
(CDH R and L) of babies with CDH in comparison with controls
(#P b .05 versus control). C, Proportion of RET-positive cells over
bronchus section. It is increased in lungs of infants with CDH
compared with controls (#P b .05 versus control).
Fig. 2 A, The number of PGP 9.5–positive nerve trunks per
bronchus in rat lungs is decreased (#P b .05 versus control) in both
lungs of animals exposed to nitrofen (N R and L and CDH R and L)
at all endpoints in comparison with control lungs (#P b .05 versus
control). B, The proportion of S100-stained glial tissue/bronchus
section in rat lungs is increased in both lungs of animals exposed to
nitrofen (N R and L and CDH R and L) in comparison with control
lungs (#P b .05 versus control).
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Fig. 3 Human: transversal section of human control (A) and CDH (B) lungs stained by S100 antibody. The amount of supporting glial cells
(arrows) is clearly increased in lungs of infants with CDH. Scale bar = 100 μm. Rat: transversal sections of rat control (C) and CDH (D) lungs
on E21 stained by S100 antibody. The proportion of supporting glial cells (arrows) is increased in bronchus of CDH fetuses, resembling the
pattern depicted in CDH human lungs. Scale bar = 100 μm.
Fig. 4 A, The expression of GDNF protein (normalized to SOD) is decreased on E15 in embryos exposed to nitrofen, whereas it remains
increased in CDH animals on E18 and E21 (⁎P b .05 versus control). B, The expression of GDNFmRNA is increased on E15 and decreased on
E18 and E21 fetuses with CDH (⁎P b .05 versus control).
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In previous studies [7,8], we found that tracheal neural
tissue was deficient in animals exposed to nitrofen, probably
because of delayed development, and, on the other hand, that
the population of supporting glial cells was increased as a
compensatory response to a neural damage. This led us to
believe that also bronchopulmonary innervation might be
abnormal in rats with CDH, and we investigated if a similar
pattern could be found in infants with CDH. Some authors
suggested that structural changes in distal airways could
justify pulmonary symptoms without involvement of
autonomic nerve abnormalities [3]. Because autonomic
nerves control the bronchial smooth muscle tone and
tracheobronchial reflexes in lower respiratory tract, we
hypothesize that impaired innervation might contribute to
explain the long-term pulmonary symptoms.
The neural crest origin of lung neural cells was elegantly
demonstrated by using a quail-chick interspecies grafting
[12] and confirmed also in our experiments by the positive
staining to p75 antibody.
Abnormalities in bronchopulmonary innervation could be
the consequence of delayed development with persistence of
immature features and/or the result of neural damage.
Moreover, a defective function of a neurotrophic factor may
also play a role. To assess the first of these hypotheses, lung
neural tissue was analyzed using the neural markers NF and
PGP 9.5; the latter stains ganglionic precursors since the early
phases of development [13], and for this reason, it was
preferred for staining embryo-fetal rat material. The number
of trunks per bronchus was significantly decreased after
exposure to nitrofen on all endpoints selected. The findings in
infants with CDH were quite similar, and the pattern in E21
rats resembled closely the human one. This pattern is
consistent with the hypothesis of a delayed development
and is similar to the one we previously described for tracheal
innervation [7].
To test the hypothesis that a neural damage occurs, we
used the S100 staining that unveils the supporting glial cells
of pulmonary ganglia. The amount of these cells was clearly
increased in animals exposed to nitrofen at all endpoints and
also in the lungs of infants with CDH. Similar increases were
interpreted as a compensation for deficient neural tissue [14].
The larger surface of S100 positive structures in lungs of
animals and infants with CDH, in which the neural fibers are
sparser, may be explained as a response to a neural damage.
This finding resembled the pattern described in the trachea of
rats with CDH [7].
We also studied the expression of RET, a receptor
tyrosine kinase expressed by neural crest-derived cells
during their migration and later required for maturation of
the peripheral nervous system [15-17]. It has been
demonstrated that RET expression is high in neural crest
cells during migration and in neural crest-derived structures
during embryogenesis, whereas it decreases in mature tissue
[17]. The increased RET expression in lungs of infants with
CDH in comparison with controls can be explained as a
persistence of enteric neuron precursors in them, in contrast
with controls in whom they were already differentiated.
Unfortunately, for technical reasons, we were unable to
analyze the expression of RET in rat lungs.
RET activation is responsive to the presence of GDNF, a
molecule that guides the innervation in the developing lung,
promoting survival, proliferation, and differentiation of
enteric nervous system progenitors into neurons and glial
cells [18,19]. In addition, GDNF acts as a chemoattractant of
these progenitors being expressed by the mesenchyme before
the entry of neural crest-derived cells [20,21], whereas the
response of abovementioned cells to GDNF diminished in
later stages of development [22,23]. The finding of persisting
high levels of GDNF protein in preterm animals with CDH,
like in earlier stages of development, is consistent with the
hypothesis of a delayed development in which mechanisms
of the immature period are maintained. In contrast, the
GDNF mRNA is decreased in preterm rats with CDH and
unable to compensate for the deficit of neural tissue found in
the lungs of those animals.
In summary, our findings confirm that bronchopulmonary
innervation is deficient in experimental and clinical CDH
probably as a result of delayed development. This deficiency
is compensated by a certain increase of the supporting glial
tissue as an expression of repair of a damage of unknown
mechanism. The fact that the lung ipsilateral and the
contralateral to the hernia were equally affected further
supports the concept of a primary developmental defect rather
than the result of lung compression during development. The
role of these anomalies that are, like other associated defects,
of neural crest origin in chronic pulmonary disease of
individuals with CDH remains to be determined.
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quantified by Western blot analysis for assessing the neural 
and muscle cell expressions. Comparisons between groups 
were made with non-parametric tests.  Results: The number 
of terminal buds, the explants’ surface and the DNA and pro-
tein contents were significantly decreased in nitrofen-ex-
posed lungs in comparison with controls. In contrast, these 
measurements were normal in explants exposed to both ni-
trofen and RA. Bronchial peristalsis (contractions/min) was 
significantly decreased in nitrofen-exposed lungs in com-
parison with controls; in contrast, in nitrofen + RA lungs it 
was similar to controls. In all study groups, the airways were 
surrounded by smooth muscle and ensheathed in a plexus 
of nerve fibers containing ganglia. PGP 9.5 protein levels 
were decreased in nitrofen-exposed lungs, but they normal-
ized when RA was added. No differences were found in  a -
actin protein levels. Explants exposed only to RA were similar 
to control.  Conclusions: Lung growth, bronchial innervation 
and peristalsis are decreased in nitrofen-exposed lung ex-
plants and are rescued by RA. If deficient airway innervation 
contributing to dysmotility and pulmonary hypoplasia can 
be pharmacologically rescued, new relatively simple prena-
tal interventions could be envisioned. 
 Copyright © 2011 S. Karger AG, Basel 
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 Abstract 
 Background: Bronchial peristalsis modulates lung growth 
and is deficient in hypoplastic nitrofen-exposed rat lung ex-
plants. Retinoic acid (RA) rescues lung hypoplasia. This study 
examines whether decreased bronchial innervation contrib-
utes to this developmental deficiency and if RA is able to
recover bronchial innervation and motility.  Material and 
Methods: After IRB approval, pregnant rats received either 
100 mg nitrofen or vehicle on gestational day 9.5 (E9.5). Em-
bryonic lung primordia harvested on E13 were cultured for 
72 h and RA was added daily to the medium when appropri-
ate. Lung growth was assessed by counting the number of 
terminal buds and measuring explant surface, total DNA and 
protein in control, control + RA, nitrofen and nitrofen + RA 
groups. Peristaltic contractions were recorded for 10 min un-
der an inverted microscope. Lung explants stained for anti-
protein gene product 9.5 (PGP 9.5) and smooth muscle  a -
actin were examined under a confocal microscope for de-
picting the specific relationship between neural and smooth 
muscle cells. PGP 9.5 and smooth muscle  a -actin levels were 
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 Introduction 
 Neural tissue and smooth muscle appear early in the 
developing fetal lung. As confocal microscopic studies 
have shown  [1] , the epithelial tubules are surrounded by 
smooth muscle and ensheathed in a network of newly-
forming nerve plexus from embryogenesis onward and 
this spatial and temporal association persists into post-
natal life. From early phases of lung development, the 
smooth muscle is functionally mature contracting in re-
sponse to agonists such as acetylcholine and histamine, 
and to electric field stimulation. The latter response is 
blocked by atropine and tetrodotoxin, meaning that the 
airway smooth muscle is innervated by functional cho-
linergic nerves  [2] . Moreover, spontaneous phasic con-
tractions have been described in freshly excised first-tri-
mester human  [3] and pig lung  [2] , and in cultures of lung 
explants from fetal mouse  [4] . Thus, there is evidence of 
strong neurogenic control of fetal airway smooth muscle.
 It has been suggested that prenatal smooth muscle 
peristalsis has a pivotal role in modulating lung growth 
 [5] . These phasic spontaneous contractions, different 
from the tonic smooth muscle activity in postnatal life 
 [6] , produce in the highly compliant developing lung a 
rhythmic mechanical stimulus that contributes to a nor-
mal airway branching and differentiation.
 Bronchial peristalsis is deficient in hypoplastic nitro-
fen-exposed rat lung explants  [5] . Moreover, we have 
demonstrated that tracheobronchial innervation is ab-
normal both in rat fetuses and newborns with CDH and 
lung hypoplasia  [7–9] .
 Given these observations, we first postulated that ab-
normalities in bronchial innervation might contribute to 
explain the pulmonary developmental deficiency. The 
close relationship between innervation and lung growth 
led us to hypothesize that agents able to rescue lung hy-
poplasia in these animals, like retinoic acid (RA) that has 
been shown to have beneficial effects on CDH lungs  [10–
12] , may also positively influence bronchial innervation 
and peristalsis.
 Material and Methods 
 Adult Sprague-Dawley female rats were mated overnight. The 
finding of spermatozoids in the vaginal smear was considered as 
a mark of gestational day 0 (E0). Pregnant rats were then random-
ly divided into two groups. The animals in the experimental 
group intragastrically received 100 mg nitrofen dissolved in olive 
oil on E9.5 to induce fetal lung hypoplasia, whereas those in the 
control group received only vehicle. On E13, the rats were sedated 
with isoflurane and killed by intracardiac injection of potassium 
chloride. The embryos were recovered and the lung primordia 
were dissected free in Hank’s buffer saline under a dissecting
microscope. The Animal Care Committee approved all the ani-
mal experiments (license No. 32-06).
 Organ Culture 
 Control and nitrofen-exposed lung explants were cultured on 
translucent polyester membrane transwell-clear inserts (Corn-
ing, Madrid, Spain) for 72 h at 37  °  C in 5% CO 2 . Culture medium 
(DMEM/F12; Gibco, Barcelona, Spain) with 10% fetal bovine se-
rum (Gibco), 100 IU/ml penicillin and 100  m g/ml streptomycin 
(Gibco) was changed every 24 h. Exogenous RA 1  m M (all- trans -
retinoic acid; Sigma, Madrid, Spain) was diluted in ethanol and 
added daily to the culture medium at a final concentration of 0.4% 
 [10] . The lungs were divided into four study groups: control (n = 
20), nitrofen (n = 20), control + RA (n = 20), and nitrofen + RA
(n = 20).
 Lung Morphometry 
 Cultured lungs were photographed daily on an inverted mi-
croscope. The digitalized images of the last culture day were ana-
lyzed with the assistance of Image Pro-Plus TM version 5.0 process-
ing software (Media Cybernetics, Washington, D.C., USA). The 
outline of the lung explant was contoured on the PC screen with 
the cursor and the resulting surface was integrated by the soft-
ware. In the same images the terminal lung buds were counted on 
each explant.
 Motility 
 At 72 h of culture, airway peristaltic contractions were record-
ed for 10 min under an inverted microscope with LAS-AF soft-
ware (TCS SP5; Leica, Barcelona, Spain) and their frequency was 
expressed as number per minute.
 Quantification of DNA and Protein Content 
 After 72 h of culture, the lung explants were snap-frozen and 
stored at –80    °    C. In half of them, DNA was extracted using 
QIAamp DNA Micro Kit (Qiagen, Barcelona, Spain) and the total 
DNA content was measured with a spectrophotometer. The re-
maining explants were homogenized in cell disruption buffer 
(Protein Isolation System Paris TM ; Ambion, Madrid, Spain) and 
the protein content was assessed using a BCA protein assay kit 
(Pierce, Madrid, Spain). Each value is the average of three mea-
surements.
 Immunohistochemistry 
 After detaching the cultured lungs from the membranes, they 
were fixed in 4% paraformaldehyde overnight and subsequently 
rinsed in phosphate-buffered saline (PBS). Non-specific binding 
was blocked by washing them in PBS with 1% bovine serum albu-
min, before incubating them with the primary antibodies over-
night. A rabbit polyclonal antibody against protein gene product 
9.5 (PGP 9.5; 1: 500; Dako Cytomation, Glostrup, Denmark) was 
used to stain the neural tissue, whereas the smooth muscle was 
identified with a mouse monoclonal anti- a -actin fluorochrome-
labeled antibody (anti-actin,  a -smooth muscle-Cy3 TM antibody; 
1: 1,000; Sigma-Aldrich, St. Louis, Mo., USA). After being washed 
with PBS, the samples were incubated at room temperature for
1 h with the fluorochrome-labeled anti-rabbit secondary anti-
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body (Alexa Fluor h 488; 1: 500; Molecular Probes, Eugene, Oreg., 
USA). After further washing with PBS, the specimens were then 
mounted into glycerol on a glass slide. As a control, the primary 
antibody was omitted with no staining above background as the 
expected result.
 Confocal Microscopy 
 Fluorescent images of the nerves and smooth muscle in the 
double-stained whole-mount preparations were obtained using a 
confocal laser scanning microscope with LAS-AF software (TCS 
SP5; Leica). The fluorescent markers were detected by a krypton/
argon laser with excitation wavelengths of 488 nm for Alexa 488 
and 561 nm for Cy3. The whole mounts were optically sectioned 
by scanning at increasing depths of focus in steps of 5  m m. After 
double staining, the green and the red images were captured sep-
arately, colorized and merged to show a composite nerve/smooth 
muscle image. The specific staining of neural structures by anti-
PGP 9.5 antibody and of smooth muscle by anti- a -actin was as-
sessed in each lung explant of the four study groups.
 Immunoblotting 
 To quantify the levels of PGP 9.5 and  a -actin proteins, six 
lungs from each group were pooled and homogenized in cell dis-
ruption buffer (Protein Isolation System Paris, Ambion). The pro-
tein content was assessed using a BCA protein assay kit (Pierce). 
Western blotting was performed with 18% SDS-polyacrylamide 
Control Nitrofen Nitrofen + RAControl + RA
  
0 h
24 h
48 h
72 h
 Fig. 1. Photographs of embryonic lung explants taken at the beginning of the culture and at 24, 48 and 72 h. RA 
rescued growth of nitrofen-exposed lung explant (fourth column). Control explant was not affected by retinoic acid 
(second column). Scale bar: 1 mm. 
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gel. Anti-PGP 9.5 (1: 6,000; rabbit polyclonal PGP 9.5; Dako) and 
 a -actin (1: 6,000; mouse monoclonal  a -actin; Sigma) antibodies 
were used and the values were normalized to superoxide dis-
mutase (SOD).
 Statistical Methods 
 The results were expressed as percentages or as means  8 SD 
and the groups were compared by non-parametric Mann-Whit-
ney tests with a threshold of significance at p  ! 0.05.
 Results 
 As expected, the surface and the number of terminal 
buds of nitrofen-exposed lung explants were significant-
ly decreased in comparison with the controls and the val-
ues were normal in those in which RA was added. In con-
trast, no changes were noticed when RA was added to 
control lungs ( fig. 1 ,  2 a, b).
 In parallel, cell mass of the explants estimated by DNA 
and protein contents was significantly decreased in nitro-
fen-exposed explants when comparing them to the con-
trols. Again, both parameters were normal if RA was add-
ed to the nitrofen-exposed explants and no changes were 
induced by this agent in controls ( fig. 2 c, d).
 Bronchial peristalsis was significantly decreased in ni-
trofen-exposed explants in comparison with controls; in 
contrast, in nitrofen + RA lungs it was similar to controls. 
There was no difference between control and control + 
RA lungs ( fig. 3 ).
 In all study groups the epithelium of the airways was 
surrounded by smooth muscle fibers, arranged in a cylin-
drical pattern, that were in turn ensheathed in a plexus of 
nerve fibers containing ganglia. The neural plexus cover-
ing the airway wall gave rise to smaller bundles that grew 
into the layer of  a -actin-positive cells. No gross change in 
the density of these structures could be seen in any of the 
groups ( fig. 4 ).
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 Fig. 2. Growth parameters analyzed in 
lung explants after 72 h of culture. The 
lung surface ( a ), the number of terminal 
buds ( b ), the total DNA content ( c ) and the 
protein content ( d ) were decreased in ni-
trofen-exposed lungs and restored to con-
trol values by RA.  #  p  ! 0.05 vs. control. 
 Fig. 3. Number of contractions per minute in control, control + 
RA, nitrofen and nitrofen + RA lung explants after 72 h of culture. 
The peristalsis was decreased in nitrofen-exposed explants and 
rescued by RA.  #  p  ! 0.05 vs. control. Three videos of airway peri-
stalsis (control [E1], nitrofen [E2] and nitrofen + RA [E3] lung 
explants) from our work are viewable on the web (online suppl. 
videos 1–3, www.karger.com/doi/10.1159/000329613). 
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 Immunoblotting 
 However, the PGP 9.5 protein signals seen at 20–25 
kDa were significantly decreased only in the nitrofen-ex-
posed explants that reverted to normal if RA was added 
( fig. 5 a). As regards  a -actin, the signals were seen at 40–
45 kDa and no differences in the protein expression 
among groups could be found ( fig. 5 b).
 Discussion 
 From early stages in gestation, the growing airways are 
surrounded by a layer of smooth muscle cells arranged cy-
lindrically around the epithelial tubules, but also by a 
nerve plexus comprising nerve trunks and ganglia, with 
fine bundles innervating the smooth muscle  [1] . Shortly 
after differentiation, the smooth muscle is able to respond 
strongly to agonists and to electrical field stimulation. At 
the same time, the airway narrowing in response to neural 
stimulation is blocked by atropine and tetrodotoxin, indi-
cating that functional cholinergic nerves are present  [2] . 
Moreover, spontaneous intermittent narrowing of the 
bronchi has been observed both in vivo and in vitro  [4] . 
The spontaneous contractions moved the lung liquid 
backward and forward along the airway lumen generating 
a positive pressure in the tubules that is considered a me-
chanical prerequisite for lung growth. When lung liquid is 
drained and hence the pressure is decreased, the lung be-
comes hypoplastic; in contrast, tracheal occlusion increas-
es the pressure and enhances lung growth. It has been ob-
served that spontaneous contractions of the airways are 
unaffected by either atropine or tetrodotoxin  [4] . The first 
finding indicates that neural activity is not essential, the 
latter shows that endogenous acetylcholine is not involved. 
In addition, this rhythmic mechanical activity ceases in 
the presence of calcium antagonists. The authors conclud-
ed that spontaneous contractions are therefore of likely 
myogenic origin  [4] . Hence, it has been supposed that the 
role fulfilled by neural tissue in early gestation is not neu-
rotransmission, but rather secretion of trophic factors for 
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after 72 h of culture. The  a -actin-positive muscle cells (red; colors refer to the online version only) formed a 
cylindrical layer around the airway wall lying perpendicularly to its long axis. PGP 9.5-positive neural tissue 
(green) invested the epithelial tubules forming a network of ganglia interconnected by nerve trunks. Fine bun-
dles descended toward the airway smooth muscle in all lungs. 
 Fig. 5.  a PGP 9.5 protein level normalized 
to SOD in all groups. The expression of 
PGP 9.5 was decreased in nitrofen-ex-
posed explants.  #  p  ! 0.05 vs. control. The 
expression normalized adding RA.  b  a -
Actin protein expression normalized to 
SOD. No differences were seen in the levels 
of the protein in the four study groups. 
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the smooth muscle that indirectly contributes to lung de-
velopment  [1, 2, 4] . Positive immunostaining for neu-
rotransmitters, like choline acetyltransferase, calcitonin 
gene-related peptide  [13] , nitric oxide synthase, vasoactive 
intestinal peptide and substance P, can be seen in the var-
icosities of the nerve fibers lying on smooth muscle cells 
later in gestation, by the end of pseudoglandular and dur-
ing canalicular stage  [1, 14] . The same authors  [1, 4, 14] 
proposed the idea that the spontaneous contractions pro-
duce a rhythmic mechanical stimulus across the airway 
wall and the adjacent parenchyma that contributes to nor-
mal airway differentiation and branching by inducing ex-
pression of growth factors. Neurotrophic factors, like 
neurturin, a member of the GDNF family, and GDNF, 
have been isolated in airway smooth muscle cells or in the 
associated mesenchymal cells  [15, 16] .
 The picture that emerges is that airway smooth muscle 
and neural tissue are an integral part of the lung from the 
onset of its development and that they exist in a dynamic 
relationship throughout gestation; hence, abnormalities 
in one part or in the other one might contribute to explain 
lung developmental deficiencies. The possible contribu-
tion of other excitatory mechanisms to airway peristalsis 
has been considered. Whereas the lung and the foregut 
have a common embryological origin  [17] , it has been 
supposed that spontaneous airway contractions resemble 
the gut peristalsis that requires c-kit-positive interstitial 
cells of Cajal (ICC)  [18] . Hence, the presence of pacemak-
er cells in the lung was investigated by some authors, but 
the ICC were not found  [19] . However, more recent re-
search supports their involvement in tracheobronchial 
muscle contractility  [20] . On the other hand, other au-
thors have demonstrated that spontaneous peristalsis 
within the explanted esophagi was not ICC-dependent, 
as the contractile behavior persisted even when ICC were 
inhibited  [21] .
 Congenital diaphragmatic hernia is a human malfor-
mation that causes high mortality in newborns because 
of severe respiratory failure secondary to pulmonary hy-
poplasia. This condition can be reproduced in rat pups by 
administrating the herbicide nitrofen (2,4-dichlorophe-
nyl- p -nitrophenyl ether) to pregnant rats; lung hypopla-
sia can be found in all pups and congenital diaphragmat-
ic hernia in most of them. An in vitro lung culture mod-
el  [4, 15] has proved to be a useful tool to investigate lung 
development and has the advantage that lung’s environ-
ment can be modified by altering the composition of the 
medium. Using this model, it has been demonstrated that 
bronchial peristalsis is deficient in hypoplastic nitrofen-
exposed lung explants  [5] .
 Given the close relationship between smooth muscle 
and neural tissue during development, we first hypothe-
sized that abnormalities in embryonic bronchial innerva-
tion might also contribute to lung hypoplasia. We pre-
viously demonstrated that tracheobronchial innervation 
is deficient in hypoplastic nitrofen-exposed rat lungs in 
terms of decrease of the neural components; moreover, 
the expression of the neurotrophic factor GDNF was im-
paired in the same lungs. The decrease of neural tissue 
was seen early (E15) and late (E21) in rat gestation and the 
final pattern resembled closely that of babies with CDH. 
On the other hand, the amount of S-100-positive sup-
porting glial cells of pulmonary ganglia was increased in 
lungs of animals exposed to nitrofen both early and late 
in gestation and also in babies with CDH  [7–9] . Recently, 
it was shown that innervation is required for epithelial 
progenitor cell function during organogenesis, because 
removal of the parasympathetic submandibular ganglion 
before the homonymous gland developed in mice, im-
paired its development reducing the number of epithelial 
buds by weakening the expression of progenitor cells. The 
same coordinated development of the peripheral nervous 
system and a branched epithelium organ is likely in the 
lung. Basal progenitor cells express the nerve growth fac-
tor receptor, whose function to date has not been clarified 
 [22, 23] .
 In the present study, we could demonstrate that in the 
nitrofen-exposed lung explants in which the frequency of 
peristaltic waves was decreased, the levels of PGP 9.5 were 
decreased as well. PGP 9.5 is a pan-neuronal marker that 
unveils ganglionic precursors since early phases of devel-
opment  [15] . Its decrease might cause an impairment in 
the signaling between nerves and airway smooth muscle, 
contributing to the hypoplasia of the lung.
 The second hypothesis was that agents able to rescue 
pulmonary hypoplasia, like RA  [10–12] , might also im-
prove bronchial innervation and peristalsis.
 Despite evidence linking retinoids with CDH dating 
back more than 50 years, it is only lately that they have 
been related to the pathogenesis of pulmonary hypoplasia 
associated with CDH  [10, 11, 24, 25] . The plasma concen-
tration of retinol and of retinol-binding protein has been 
found decreased in newborns with CDH in comparison 
with controls. Those values were independent of mater-
nal retinol status that was similar to controls for some 
authors  [26] , while higher than controls for others  [27] . 
These findings supported the idea that human CDH is 
linked to abnormal retinoid homeostasis. It has been 
demonstrated that exogenous RA is able to increase the 
size of hypoplastic lung explants  [10, 24] . Moreover, RA 
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induces FGF-10 expression in the foregut region where 
the lung forms  [28] . Thus, since FGF-10 governs the di-
rectional outgrowth of lung bud during branching mor-
phogenesis  [29] , RA signaling may connect formation of 
the laryngotracheal groove with activation of FGF-10-de-
pendent bronchial morphogenesis  [30] . FGF-10 is pro-
duced by airway smooth muscle progenitors and is re-
quired for their entry into the smooth muscle cell lineage 
 [31] .
 In our experiments, RA not only significantly in-
creased lung growth in nitrofen-exposed lung explants, 
as previously demonstrated  [10] , but it restored the hypo-
plastic lungs to the size, the number of terminal buds and 
the DNA and protein content of the control lungs. The 
frequency of peristaltic waves, that was decreased in ni-
trofen-exposed lungs, normalized adding RA to the me-
dium. The improvement of airway peristalsis obtained 
with RA was not related to smooth muscle hypertrophy, 
because the expression of smooth muscle-specific marker 
 a -actin was not increased in RA-treated groups. On the 
other hand, the levels of the pan-neuronal protein PGP 
9.5 decreased in nitrofen-exposed lung explants were re-
stored by RA. RA signaling has been found to play a role 
in neurite outgrowth both in vitro and in vivo  [32] .
 This study demonstrated for the first time that bron-
chial neural tissue is deficient in nitrofen-exposed lung 
explants and that it is rescued, together with airway peri-
stalsis and lung growth, by RA, suggesting that not only 
smooth muscle and peristalsis, but also bronchial neural 
tissue might contribute to lung development.
 Studies like the present one, based on teratogenic ani-
mal models of malformations, may be criticized because 
it is not known whether the anomalies found are due to 
the direct effects of the chemical used or to the malforma-
tion induced by it. However, since its first description, the 
nitrofen rat model of CDH has evolved into a well-estab-
lished one that faithfully reproduces the phenotypic fea-
tures of the human condition including skeletal  [33] , car-
diovascular  [34] and lung malformations  [9] as well as 
anomalies of the esophageal innervation  [35, 36] suitable 
for research into this particular condition. It is therefore 
likely that the findings of the present study could also be 
present in human CDH patients, opening a new possible 
field of prenatal intervention for fetuses with CDH and 
lung hypoplasia.
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ABSTRACT 
 
Background: Lung hypoplasia can be prevented in vitro by retinoic acid (RA). Recent 
evidence suggests that amniotic fluid stem (AFS) cells may integrate injured lungs and 
influence their recovery. We tests the hypothesis that AFS cells might improve lung 
growth and motility by paracrine mechanisms. 
Material and methods: Pregnant rats received either nitrofen or vehicle on E9.5. In 
vitro E13 embryonic lungs were cultured in presence of culture medium alone or with 
RA, basophils or AFS cells. In vivo GFP+rat-AFS-cells were transplanted in nitrofen-
exposed rats on E10.5. E13 lung explants were cultured before analysis. The surface, 
the number of terminal buds and the frequency of bronchial contractions were 
assessed?? ???? ???? ???? ?-actin protein levels were measured. The lung explants 
??????????????????????????????????????????????-actin, PGP9.5 and TTF-1. ??????????????
???? ?????? ??????? ????????? ??? ???? ???? ?????? ??? ???? ????????????????????????????? 
Comparison between groups was made by Anova tests. 
Results: In vitro The surface, the number of terminal buds and the bronchial peristalsis 
were increased in nitrofen+AFS-cells explants in comparison with nitrofen-exposed 
lungs. While nitrofen+RA lungs were similar to nitrofen+AFS ones, basophils did not 
normalize these measurements. PGP9.5 protein was decreased in nitrofen lungs, but 
after adding AFS cells, the value was similar to controls. No differences were found in 
???? ??????????? ??? ?-actin. In vivo Surface, number of terminal buds and peristalsis 
were similar to control after injection of AFS cells in nitrofen-exposed rats. 
Colocalization with TTF-1-positive cells was found. ???? ??????? ??? ?????? ???? ??????
were increased in nitrofen+AFS-?????????????????????????????????? ?????????????????????
similar to controls. 
Conclusions: Lung growth, bronchial motility and innervation are decreased in nitrofen 
explants and rescued by AFS cells both in vitro and in vivo, similarly to what observed 
before with RA. AFS cells beneficial effect was probably related to paracrine action of 
growth factors secretion.  
     
 
Key Words: Diaphragmatic hernia, amniotic fluid stem cells, intrinsic innervation, 
Nitrofen, peristalsis, lung hypoplasia, retinoic acid. 
     
 
INTRODUCTION 
Severe pulmonary hypoplasia contributes significantly to the mortality and morbidity 
in newborns with congenital diaphragmatic hernia (CDH). Despite the improvements in 
neonatal resuscitation and intensive care, the mortality rate of CDH is still high and 
most of the newer treatment modalities have replaced mortality for a higher 
morbidity. Long-term pulmonary sequelae are frequently described in survivors of CDH 
and depend on the severity of lung hypoplasia and the degree of lung injury 
(16,21,30,33,40,42,43).  
Since the first description of nitrofen-induced diaphragmatic hernia in rodents by 
Iritani (17), this experimental model has been extensively studied and has become a 
widely accepted model which closely replicates many features of the human condition 
(15,22). Different treatment modalities have been tried in the experimental model of 
CDH in an attempt to modulate prenatally the natural course of the malformation. 
Among those, retinoic acid (RA) has been demonstrated to prevent pulmonary 
hypoplasia in vitro, to stimulate alveologenesis and to accelerate alveolar cell 
proliferation in hypoplastic lungs (25-27,35). However, limitations on the clinical use of 
RA, which is known to be teratogenic (8,41), provide an opportunity to explore 
alternative procedures for the rescue of this devastating disease.  
Stem cell-based therapies are promising new treatment approaches for a large number 
of diseases. Recently, it has been reported that amniotic fluid-derived stem (AFS) cells 
can be isolated from human and rodent amniotic fluid. AFS cells are broadly 
multipotent cells, able to differentiate into lineages belonging to all three embryonic 
germ layers (10). Moreover, they can also engraft in irradiated bone marrow and give 
rise to all hematopoietic lineages (13). Finally, they can functionally contribute to the 
regeneration of various tissues and organs when transplanted in models of disease. 
Remarkable results have been obtained in injured kidneys, heart and lungs (3,31,47). 
The latter have been explored both in models of diseases and during development and 
AFS cells have shown the potential not only to engraft and differentiate in specialised 
     
 
pneumocytes but also to contribute and supplement endogenous lung repair 
mechanisms (7). 
The aim of this study was to test the hypothesis that AFS cells could rescue lung 
growth and motility both in vitro and in vivo and to look further inside the mechanism 
of action of AFS cells. 
MATERIAL AND METHODS 
Adult Sprague-Dawley female rats (Harlan Laboratories, Barcelona, Spain) were 
mated overnight. The finding of spermatozoids in the vaginal smear was considered 
as a mark of gestational day 0 (E0). Pregnant rats were then randomly divided into 
two groups. The animals in the experimental group received intragastrically 100 mg 
of nitrofen dissolved in olive oil on E9.5 to induce fetal lung hypoplasia, whereas 
those in the control group received only vehicle.  
In vitro On E13, the rats were sedated with isofluorane and killed by intracardiac 
injection of potassium-chloride. The embryos were recovered (Figure 1) and the lung 
primordia were dissected free in Hank’s buffer saline (HBSS) under a dissecting 
microscope.  
In vivo On E10.5 a laparotomy was performed and, after exposure of the uterus, 
1x10
5
-10
6
 GFP+ rat-AFS cells, previously trypsinized, were injected into amniotic fluid 
of nitrofen-exposed and control rats. On E13, as described above, the rats were 
sacrificed, the embryos recovered and the lung primordia were freed carefully from 
the heart and the esophagus (Figure 1).  
The Animal Care committee approved all the animal experiments (license number: 
32-06). 
 COLLECTION AND CHARACTERIZATION OF THE RAT AFS CELLS: samples of 
rat amniotic fluid were collected from transgenic GFP-positive pregnant Sprague-
Dawley rats on E16 and GFP-rAFS cells were isolated and cultured, as prevoiusly 
described (4,10,13).  
     
 
GFP-rAFS cells characterization was carried out with the following primary 
antibodies: anti-Oct 3/4 (mouse monoclonal, Santa Cruz Biotechnologies®, CA, 1:50), 
anti-CD45 (rabbit polyclonal, Abcam®, London, UK, 1:100), anti-CD34 (rabbit 
polyclonal, Abcam®, London, UK, 1:150), anti-pan cytokeratin (mouse monoclonal 
Abcam®, London, UK, 1:300), anti-vimentin (mouse monoclonal Abcam®, London, 
UK, 1:1000) and anti-alpha smooth muscle actin (????? ouse monoclonal Abcam®, 
London, UK,  1:100). Cover glass seeded with 2000 cells/cm
2
 were rinsed in 
phosphate buffered saline (PBS) and fixed in 4% paraformaldehyde for 20 minutes. 
Cells were permeabilized with a 0.5% Triton X-100 solution, rinsed in PBS with 3% 
bovine-serum albumin to block nonspecific binding and incubated with primary 
antibodies for 1 hour at room temperature. After being washed with PBS, the 
samples were incubated at room temperature for 1 hour with the fluorochrome-
labeled anti-mouse and anti-rabbit secondary antibodies (Alexa Fluor? 594; 1:150; 
Molecular Probes, Invitrogen, London, UK). After further washing with PBS, the 
specimens were then mounted into fluorescent medium with DAPI (1.5 ?g/ml) on a 
polylysine slide (ThermoScientific, London, UK) and observed under epifluorescence 
microscope (ZEISS Axiophot).  
Cell count were blindly evaluated for each stained slide over three low magnification 
fields (x10) and reported in the chart as percentage. 
 ORGAN CULTURE: In vitro The lung explants were divided into eight study 
groups: control (n=8), nitrofen (n=12), control + RA (n=8), nitrofen + RA (n=12), control 
+ basophils (n=8), nitrofen + basophils (n=12), control + AFS cells (n=8), nitrofen + AFS 
cells (n=12).  
Control and nitrofen-exposed lung explants were cultured on translucent membrane 
inserts (polyester membrane transwell-clear inserts, pore size: 3 ????????????? ???????
Spain) for 72 hours at 37°C in 5% CO2. Culture medium (D-MEM/F12, Gibco, Barcelona, 
Spain) with 10% fetal bovine serum (Gibco, Barcelona, Spain), 100 IU/ml penicillin and 
???????????????????????????????????????????????????????????????l the lungs were lying 
on the air-medium surface and changed every 24 hours.  
     
 
When lung explants were co-??????????????????????????????????????????????????-trans-
retinoic acid, Sigma, Madrid, Spain) was diluted in ethanol and added daily to the 
culture medium at a final concentration of 0.4% (25).  
When basophils needed to be added, the day before recovering the embryos, rat RBL 
2H3 were trypsinized and 5000 cells/cm
2
 were cultured on culture dishes (12 well 
culture dish, Corning, Madrid, Spain) in D-MEM medium (D-MEM/F12, Gibco, 
Barcelona, Spain) with 10% fetal bovine serum (Gibco, Barcelona, Spain), 100 IU/ml 
???????????????????????????????????????????????????????????????? 
When lung expants were co-cultured in presence of AFS cells, the day before 
harvesting the embryos, rat AFS cells were trypsinized and 5000 cells/cm
2
 were 
????????? ??? ???????? ??????? ???? ????? ???????? ?????? ????????? ???????? ??????? ??? ?-MEM 
medium containing 15% ES-FBS, 1% glutamine, 1% penicillin/streptomycin (Gibco, 
Barcelona, Spain) supplemented with 18% Chang B and 2% Chang C (Irvine Scientific, 
Santa Ana, California) at 37°C with 5% CO2 atmosphere (10). Before placing the inserts 
on the culture dishes, the medium was removed and replaced with D-MEM medium.  
In vivo Control (n=8) and nitrofen-exposed (n=12) lung explants were cultured on 
translucent membrane inserts (polyester membrane transwell-clear inserts, Corning, 
Madrid, Spain) for 72 hours at 37°C in 5% CO2. Culture medium (D-MEM/F12, Gibco, 
Barcelona, Spain) with 10% fetal bovine serum (Gibco, Barcelona, Spain), 100 IU/ml 
??????????? ?????????????? ????????????? ??????????????????? ??????????? ???????????? ????
lungs were lying on the air-medium surface and changed every 24 hours.  
 LUNG MORPHOMETRY: Cultured lungs were photographed daily on an 
inverted microscope. The digitalised images of the last culture day were analysed 
with the assistance of image processing software (Image Pro-Plus
TM
, version 5.0, 
Media Cybernetics, Washington, DC, USA). The outline of the lung explant was 
contoured on the PC screen with the cursor and the resulting surface was integrated 
by the software. In the same images the terminal lung buds were counted on each 
explant. 
     
 
 MOTILITY: At 72 hours of culture, airway peristaltic contractions were 
recorded for 10 minutes under an inverted microscope with LAS-AF software (Leica 
TCS SP5, Barcelona, Spain) and their frequency was expressed in number per minute. 
IMMUNOBLOTTING: To quantify the levels of PGP 9.5 and ?-actin proteins, 
five lungs from control, nitrofen, nitrofen + RA and nitrofen + AFS cells groups were 
pooled and homogenized in cell disruption buffer (Protein Isolation System Paris
TM
, 
Ambion, Madrid, Spain). The protein content was assessed using a protein assay kit 
(BCA Protein Assay Kit, Pierce, Madrid, Spain). Western blotting was performed with 
18% SDS-polyacrylamide gel. Anti-PGP 9.5 (1:6000; rabbit polyclonal PGP 9.5; Dako 
???????????? ?????????? ????????? ???? ?-actin (1:?????? ?????? ??????????? ?-actin, 
Sigma, Madrid, Spain) antibodies were used and the values were normalized to SOD.  
  IMMUNOHISTOCHEMISTRY: After detaching the in vivo group nitrofen-
exposed cultured lungs from the membranes, they were fixed in 4% 
paraformaldehyde overnight and subsequently rinsed in phosphate buffered saline 
(PBS). Nonspecific binding was blocked by washing them in PBS with 1% bovine-
serum albumin, before incubating them with the primary antibodies overnight. To 
evaluate the AFS cells differentiation towards neuronal, muscle and epithelial 
lineage, three stainings were performed. 
In the first, a mouse monoclonal antibody against protein gene product 9.5 (PGP 9.5; 
1:500; Acris antibodies, Barcelona, Spain) was used to stain the neural tissue. In the 
second, smooth muscle was identified with a mouse monoclonal anti-?-actin 
fluorochrome-labeled antibody (anti-actin, ?-smooth muscle-Cy3TM antibody; 
1:1000: Sigma-Aldrich, St. Luis, MO). In the third, the epithelial cells were stained 
with monoclonal mouse anti-thyroid transcription factor (TTF-1, Dako Cytomation, 
Glostrup, Denmark). 
In all experiments, the anti-green fluorescent protein rabbit IgG fraction (anti-GFP, 
IgG; Molecular Probes, Eugene, Oregon) unveiled the injected AFS cells. After being 
washed with PBS, the samples were incubated at room temperature for 1 hour with 
     
 
the fluorochrome-labeled anti-rabbit and anti-mouse secondary antibodies (Alexa 
Fluor? 488 and 568; 1:500; Molecular Probes, Eugene, Oregon). After further 
washing with PBS, the specimens were then mounted into glycerol on a glass slide. 
As a control, the primary antibody was omitted with no staining above background 
as the expected result. 
 CONFOCAL MICROSCOPY: Fluorescent images of the nerves, smooth muscle, 
epithelial cells and the injected AFS cells in the double-stained whole mount 
preparations were obtained using a confocal laser scanning microscope with LAS-AF 
software (Leica TCS SP5, Barcelona, Spain). The fluorescent markers were detected 
by a kripton/argon laser with excitation wavelenghts of 488 nm for Alexa 488, 568 
nm for Alexa 568 and 561 nm for Cy3. The whole mounts were optically sectioned by 
scanning at increasing depths of focus in steps of 5 ?m. After double staining, the 
green and the red images were captured separately, colorized and merged to show a 
composite image. The specific staining of neural structures by anti-PGP 9.5 antibody, 
of smooth muscle by anti-?-actin antibody and of epithelial cells by anti-TTF-1 
antibody and the percentage of colocalization were assessed in each lung explant. 
TOTAL RNA EXTRACTION AND RETROTRANSCRIPTION: Trypsinized AFS cells 
harvested from the culture setting of 8 control lungs co-cultured with AFS cells and 12 
nitrofen-exposed explants co-cultured with AFS cells were suspended in sterile RNase 
free 1.5 ml microcentrifuge tubes and centrifuged for 1 minute to pellet the cells. After 
pouring off the supernatant, 1 ml of TRIzol Reagent (Life Technologies cat# 15596-026) 
was added to the tubes. Cells were lysed by thorough pipetting. The homogenate was 
then centrifuged at 12,000 x g for 10 minutes at 4°C. Homogenate was then 
transferred in a sterile microcentrifuge tube. The samples were incubated for 5 
minutes at room temperature. 0.2 ml of Chloroform was added to each tube. Samples 
were shaken vigorously by hand for 15 seconds, incubated at room temperature for 5 
minutes then centrifuged for 15 minutes at 12,000 x g at 4°C. The upper aqueous 
phase was transferred to a fresh tube. 0.5 ml of isopropyl alcohol was added to 
precipitate RNA. Samples were incubated at room temperature for 5 minutes and 
     
 
centrifuged at 12,000 x g for 10 minutes at 4°C. Supernatant was discarded and pellet 
was washed with 1 ml 75% ethanol. The sample was mixed by vortexing and 
centrifuged at 7,500 x g for 5 minutes at 4°C. Supernatant was then removed and 
pellet left to air dry for 5-10 minutes. Pellet was dissolved in RNase free water or 0.5% 
SDS by passing the solution through a pipette tip and incubating for 10 minutes at 55-
60°C. RNA concentration and purity of the sample were assessed by pipetting the 
diluted RNA sample in to a clean cuvette and absorbance was read at 260 nm and 280 
nm. In order to determine the purity of the RNA sample, ratio of A260/A280 was 
calculated. We analyzed only samples with ratios ranging between 1.6 and 2, which 
represent a good RNA extraction. The first-strand cDNA was synthesized using 1 ?g of 
total RNA in a total volume of 8 ?l of DEPC water.  After 1 ?l of DNAse treatment, the 
mix was heated at 65°C for 10 min and 1 ?l OligoDT plus 1 ?l dNTPs mix 10 mM were 
added. The solution was then heated for 5 minutes at 65°C then cooled at 4°C, added 4 
?l of First Strand Buffer x5, 2 ?l 0.1 M DTT, 1 ?l RNaseOUT™ and after a preheating at 
42°C for 2 minutes, 1?l of Taq Polymerase (Invitrogen, London, UK) was added and left 
for 50 minutes at 42°C and then for 15 minutes at 70°C. Lastly 1 ?l of RNAse H was 
added and the solution was incubated for 20 min at 37°C. The generated cDNA was 
???????????????????????????????????????????? 
PRIMER DESIGN AND REAL TIME PCR: Real-time PCR oligonucleotide primers 
(Tab. 1) were manually designed for each of the genes to assure maximal efficiency 
and sensitivity, according to the following parameters: primer length, melting 
temperature and avoidance of the formation of self and hetero-dimers, hairpins and 
self-complementarity. These properties were verified using two different internet-
based interfaces: Primer-3 and Oligonucleotide Properties Calculator. When possible, 
"GC clamps" were placed at the 3'-end of each primer to minimize breathing between 
primer and template DNA, which can promote mispriming and decrease efficiency. 
Primers were designed such that amplicon sizes ranged between 50 and 250 bps. 
Melting curve analysis was always performed at the end of each PCR assay to control 
the specificity; definite reactions should result in a single melting peak corresponding 
to the PCR product being amplified. Real-time PCR was performed using the default 
     
 
thermocycler program for all genes: 3 minutes of pre-incubation at 94°C followed by 
50 cycles for 30 seconds at 94°C, 30 seconds at 60°C and 45 seconds at 72°C. Individual 
real-time PCR reactions were carried out in 30 ?l volumes in a 96-well plate (Applied 
Biosystems™, London, UK) containing 8 ?l DEPC water, 1 ?l of sense and antisense 
primers (10 ?M) and 15 ?l SYBR Green with ROX ® plus 5 ?l of sample. At the end of 
each reaction, cycle threshold (Ct) was manually set up at the level which reflected the 
best kinetic PCR parameters, and melting curves were acquired and analyzed. 
We used a relative quantification method to measure gene expression by relating the 
PCR signal of the target transcript in a treatment group to control AFS cells of 
comparable passage number cultured for 72 hours at 37°C in 5% CO2 in D-MEM/F12 
medium with 10% fetal bovine serum?? ???? ?????? ??????????? ???? ???? ??????
streptomycin. In this work, the 2-??Ct method of relative quantification was adapted 
to estimate copy numbers in our target genes. The ??Ct calculation for the relative 
quantification of target was used as follows: ??Ct = (Ct, target gene – Ct, ?2 
microglobulin)? – (Ct, target gene – Ct, ?2 microglobulin)y, where ? = unknown sample 
and y = AFS cells control. After validation of the method, results for each sample were 
expressed in N-fold changes in ? target gene copies, normalized to ?2 microglobulin 
relative to the copy number of the target gene in AFS cells control, according to the 
following equation: amount of target = 2-??Ct. A minimum of two experiments were 
carried out for each gene and sample. At each experiment, each individual sample was 
run in duplicate wells and the Ct of each well was recorded at the end of the reaction. 
The average and standard deviation (SD) of the three Cts were calculated and results 
for each sample were expressed as the N-fold copy number of a given gene relative to 
AFS cells  control as expressed by calculating the geometric mean between the two 
experiments. 
STATISTICAL METHODS: The results were expressed as percentages or as 
means±SD and the groups were compared by Anova tests with a threshold of 
significance at p<0.05. Tukey’s range test was used as post-hoc test.  
 
     
 
RESULTS 
Thirty adult Sprague-Dawley pregnant rats were randomised to receive 
nitrofen or vehicle at E9.5. All animals survived to the procedure and were sacrificed 
at E13. Fetuses were collected and a total of 80 embryonic lungs were isolated under 
dissecting microscope and cultured in defined condition (see methods and Fig. 1). An 
additional culture set was dedicated to observe 20 lungs derived from control and 
nitrofen-exposed fetuses, which received, at E10.5, an in utero transplantation of 
AFS cells (Fig. 1). This procedure was however associated to a high mortality and 
only 15% of embryos survived. We continued the injections of AFS cells in utero until 
we obtained 20 lungs (12 nitrofen exposed lungs and 8 control lungs) to study. 
Similarly to the first group, animals were sacrificed at E13 and the harvested lungs 
underwent to in vitro culture for 72 hours.  
GFP-rAFS cells expressed the marker Oct 3/4. CD34, CD45 and pan-
cytokeratin were absent, while the mesenchymal cell marker vimentin and the 
??????? ?????? ??????????? ????????????????????????????Fig. 2). 
Embryonic lungs appeared dramatically different among the groups. In 
particular, as described before (25), embryonic lungs of fetuses which were exposed 
to nitrofen showed a marked hypoplasia, which appeared not influenced by 
basophils co-culture (Fig. 3). On the contrary, it appears that embryonic lungs which 
were exposed to nitrofen but cultured in presence of AFS cells or RA, did not differ 
from the ones derived from normal control animals (Fig. 3A). Remarkably this was 
also the case of the nitrofen-exposed lungs transplanted in utero with AFS at E10.5 
and harvested at E13 (Fig. 3A). 
To confirm this quality aspect, both lung surface and number of terminal 
buds were blindly measured. Similarly to what has been reported before (25), both 
surface (nitrofen  0.3 ± 0.12 mm
2 
vs control 0.56 ± 0.17 mm
2
, p<0.005; Fig. 3B) and 
number of terminal buds (nitrofen 41 ± 9 vs control 63 ± 8, p<0.005; Fig. 3C) were 
significantly decreased in nitrofen-exposed lung explants in comparison with the 
controls and the values did not normalize after being co-cultured with basophils 
     
 
(surface: nitrofen + basophils 0.34 ± 0.19 mm
2
 vs control 0.56 ± 0.17 mm
2
, p<0.005; 
buds: nitrofen + basophils 36 ± 4 vs control 63 ± 8, p<0.005; Fig. 3B and C). In 
contrast, both parameters showed normalization in these lungs co-cultured in 
presence of AFS cells (surface: nitrofen + AFS cells 0.50 ± 0.08 mm
2 
vs control 0.56 ± 
0.17 mm
2
, p=0.17; buds: nitrofen + AFS cells 60 ± 11 vs control 63 ± 8, p=0.42; Fig. 3B 
and C) or when RA (surface: nitrofen + RA 0.50 ± 0.07 mm2 vs control 0.56 ± 0.17 
mm
2
, p=0.18; buds: nitrofen + RA 61 ± 6 vs control 63 ± 8, p=0.47) was added to the 
culture medium (Fig. 3B and C). The latter were confirmed also when AFS cells were 
transplanted in utero (surface: in vivo nitrofen + AFS cells 0.48 ± 0.08 mm
2 
vs control 
0.56 ± 0.17 mm
2
, p=0.19; buds: in vivo nitrofen + AFS cells 56 ± 14 vs control 63 ± 8, 
p=0.17; Fig. 3B and C). 
Importantly, no changes were noted when basophils, AFS cells or RA were 
added to control lungs (data not shown). 
Among the various functional parameters which could be evaluated, 
peristalsis may play a pivotal role for the normal development of embryonic lungs 
(34). After video recording, samples were examined blindly and showed that rescue 
of normal development by AFS cells is also evident by the normalization of peristaltic 
movement. In fact, while bronchial peristalsis was significantly decreased in nitrofen-
exposed explants in comparison with controls (nitrofen 0.5 ± 0.1 
contractions/minute vs control 0.9 ± 0.1 contractions/minute, p<0.005; Fig. 3D), in 
nitrofen + AFS cells (0.9 ± 0.2 contractions/minute vs control 0.9 ± 0.1 
contractions/minute, p=0.69; Fig. 3D) as well in nitrofen + RA (0.8 ± 0.2 
contractions/minute vs control 0.9 ± 0.1 contractions/minute, p=0.77; Fig. 3D) lungs 
it was similar to normal controls. Interestingly, the presence of basophils did not 
influence the functional movement of the embryonic lungs, which remained 
impaired (nitrofen + basophils 0.6 ± 0.07 contractions/minute vs control 0.9 ± 0.1 
contractions/minute, p<0.005; Fig. 3D). In contrast, the transplantation in utero of 
AFS cells resulted in the restoration of regular peristalsis in the nitrofen-exposed 
     
 
lungs (Fig. 3D). Normal controls in medium did not differ from the exposed to RA or 
AFS cells (data not shown). 
It has been suggested that both airway smooth muscle and neural tissue 
contribute to normal airway differentiation and branching from the early stages of 
development. To see whether the growth of neural tissue and smooth muscle were 
normal in lung explants, PGP 9.5 and ?-actin protein levels were assessed. PGP 9.5 is 
a pan-neuronal protein that reveals neurons and their processes from the onset of 
lung development. The PGP 9.5 protein signals were seen at 20-25 kd. Similarly to 
what has been demonstrated before (29), the PGP 9.5 protein levels were 
significantly decreased in the nitrofen-exposed explants when compared to controls 
and the values did not normalize in presence of basophils (Fig. 4A). In contrast, PGP 
9.5 expression was rescued to normal values when the nitrofen-exposed explants 
were co-cultured with AFS cells (Fig. 4A). This is similar to what is obtained when RA 
is administrated (Fig. 4A), as demonstrated before (29). Differently, ?-actin did not 
differ among the groups (Fig. 4B).  
When we analysed the nitrofen-exposed cultured lungs after in utero AFS 
cells transplantation, confocal microscopy revealed that GFP+ AFS cells were 
diffusely present on the bronchial tree, but, interestingly, they did not colocalize 
with ?-actin- or PGP9.5-positive cells (Fig. 5A and B). In contrast, 50-70% of GFP+ 
AFS cells colocalized with TTF-1-positive cells (Fig. 5C and D). TTF-1 is a marker for 
alveolar epithelial cells type II (AECs-II) and it has been found to be essential for 
branching and for lung surfactant protein A and B production by the AECs-II. We 
postulated however that differentiation was not essential for the therapeutic effect 
since the lungs were rescued also when not exposed in direct contact to AFS cells. In 
this setting the AFS cells were lying attached on the bottom of the well and no 
GFP+cells were seen floating in the medium or on the membrane close to the lung 
explant. To evaluate whether the beneficial effect of stem cells could be mediated by 
paracrine mechanisms through secretion of growth factors (9) we evaluated the 
levels of three growth factors involved in lung morphogenesis in the culture medium 
     
 
of nitrofen-exposed lungs co-cultured with AFS cells and compared to those of a 
control. FGF10, which has a pivotal role in modulating embryonic lung branching 
morphogenesis and cytodifferentiation, ???? ??????? ?????????? ????? ??? ? ????????
role in the angiogenesis, were significantly higher expressed in the medium of 
nitrofen-exposed lung explants co-cultured with AFS cells (Fig. 6A and B). In contrast, 
??????????????????????????????????????????????????r of lung epithelial proliferation 
and differentiation, was similar to controls (Fig. 6C).  
DISCUSSION 
Congenital diaphragmatic hernia is a malformation still causing mortality in newborns 
mainly because of severe respiratory failure secondary to pulmonary hypoplasia. This 
condition can be reproduced in pup rats by administrating the herbicide nitrofen (2,4-
dichlorophenyl-p-nitrophenyl ether) to the pregnant mothers. In this model, lung 
hypoplasia is usually found in all pups and a diaphragmatic hernia in most of them (17). 
These lungs can be easily cultured in vitro and this has been very useful to investigate 
lung development, which can be generally influenced by altering the composition of 
the medium (18,34,38). 
Using this setting, we have demonstrated for the first time that AFS cells are able to 
rescue both in vitro and in vivo hypoplastic nitrofen-exposed embryonic lungs. This is 
comparable to the rescue obtained when hypoplastic nitrofen-exposed embryonic 
lungs were cultured in presence of exogenous RA (25,27,28,35). The mechanism of 
action has not been fully elucidated, but it has been demonstrated that nitrofen 
inhibits RALDH 2, that catalyzes the final step in RA production (24). Therefore, the 
increase in lung branching morphogenesis in nitrofen-induced hypoplastic lungs 
exposed to exogenous RA is consistent with the hypothesis that the decrease of RALDH 
2 activity can be partially countered by the increase of substrate (2).  
In our experimental conditions, RA, which was used as positive control, restored 
indeed the hypoplastic lungs to the size and the number of terminal buds of the 
control lungs. The frequency of peristaltic waves, that was decreased in nitrofen-
exposed lungs, normalized after  adding RA to the medium. While interesting to 
     
 
explore different pathways which could be involved in the hypoplastic lungs and their 
rescue, RA has the limitations of not being suitable to be used in the clinic (8,41) and 
alternative therapeutic options are needed.  
It has been recently demonstrated that the pluripotent AFS cells (10) are able 
to integrate into developing as well as injured lung tissue, influencing its recovery 
from injury, and differentiate into lung epithelial lineages (7). In the present study, 
we found that hypoplastic nitrofen-exposed lung explants co-cultured with AFS cells 
were restored to the size and the number of terminal buds of the control lungs. 
Moreover, the frequency of peristaltic waves, that was decreased in nitrofen-
exposed lungs, as expected (20), normalized after adding AFS cells to the medium. 
The improvement of airway peristalsis obtained with AFS cells as well as with RA was 
not related to smooth muscle hypertrophy (19,29), because the expression of 
smooth muscle-specific marker ?-actin was not increased in AFS cells or RA treated 
groups. In contrast, the levels of PGP 9.5, a pan-neuronal marker that unveils 
ganglionic precursors since early phases of development (39), were decreased in 
nitrofen-exposed lungs and they normalized after adding the AFS cells or RA to the 
medium. 
In order to mimic a possible therapeutic approach, we subsequently tested whether 
AFS cells could be therapeutic in nitrofen-exposed pregnant rats. Indeed lung growth 
and motility, evaluated after harvesting and culturing the embryonic lungs, could be 
rescued when AFS cells were injected in pregnant rats one day after the administration 
of the nitrofen. This could be observed in spite of a high rate of in uterus embryonal 
mortality, being the overall survival 15%. To determine whether AFS cells were able to 
differentiate into neural, muscle or epithelial lineages after integration, we analyzed 
the colocalization of GFP+ AFSC with PGP9.5+ or ?-actin+ or TTF-1+ cells. We found 
that AFS cells colocalized with TTF-1+ cells. 
Despite the minimal indication of engraftment, the main therapeutic effect produced 
by AFS cells seems mediated by paracrine mechanisms elicited through trophic 
mediators (5,9,14,32,36,37), as evident by the co-culture experiments. Among the 
     
 
various factors which could be driving this effect, FGF-???? ?????? ???? ?????? ?????
evaluated in this study. FGF-10 is essential for lung branching morphogenesis having a 
central role in inducing the spatial coordinates for patterning the epithelial tubules. 
????????????????????????????? ?????????????? ?????????t to prevent local budding and to 
maintain proximal airways in an unbranched form by suppressing epithelial cell 
proliferation and by promoting synthesis of extracellular matrix components around 
????????????????????????????????????????????????????????????signaling is responsible for 
the differentiation of embryonic mesenchymal cells into endothelial cells; the 
interaction between the epithelium and mesenchyme contribute to lung 
neovascularisation that is crucial in normal lung development (6,11,23,45,46,48). 
Interestingly, we found that the levels of FGF-????????????????????????????????????????
increased in comparison with controls when nitrofen-exposed lung explants were co-
cultured with AFS cells. These findings were consistent with the demonstration that 
the temporospatial pattern of FGF-10 expression is severely disrupted in the presence 
of nitrofen-induced lung hypoplasia, whereas exogenous FGF-10 can rescue 
hypoplastic lungs in culture (1). This is also consistent with the fact that it has recently 
been shown that also RA has a major role in early lung morphogenesis by inducing 
FGF-10 expression within the mesoderm subjacent to the site of origin of the 
laryngotracheal groove (12). It is possible that AFS cells are capable to produce high 
levels of FGF-10 in response to the damaged lungs which they are exposed to (44). 
In conclusion, we have demonstrated for the first time that AFS cells can rescue 
nitrofen-induced hypoplastic lungs in co-culture. It is possible that, as previously 
demonstrated in other model of disease, AFS cells might have a therapeutic role in 
CDH, particularly in babies with severe hypoplastic lungs. This effect could be also 
obtained during the gestation since AFS cells  transplanted in utero in the same animal 
model produced similar effect. 
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TABLE 
Table 1  
Primer template table 
 Forward Primer Reverse Primer 
rB2M 5’-GGCACGATGGCTCGC-3’ 5’-TCCCATTCTCCGGTGGAT-3’ 
rFGF10 5’-TCCGCTGGAGAAAGCTGTTC-3’ 5’-GTTAATGGCTTTGACGGCAAC-
3’ 
rVEGFa 
 
5’-CTGCAAAAACACAGACTCGCGT-3’ 5’-AGGACTGTTCTGTCGACGGTG-
3’ 
rTGFb1 
 
5’-GCTGAACCAAGGAGACGGAA-3’ 5’-GAAGGGTCGGTTCATGTCATG-
3’ 
 
 
LEGENDS FOR THE FIGURES 
Figure 1 
In the in vitro model, pregnant rats received intragastrically either nitrofen 
or vehicle on E9.5. On E13 the embryos were recovered and the lung 
primordia harvested. 
In the in vivo model, pregnant rats received intragastrically either nitrofen 
or vehicle  on E9.5. A laparotomy was performed on E10.5 and 1x10
5
-10
6
 
GFP+ rat-AFS cells were injected into the amniotic fluid of both groups. The 
embryos were recovered on E13 and the lung primordia were dissected 
free. 
     
 
Figure 2 
Immunophenotyping of GFP-rAFS cells. More than 90% of GFP-rAFS cells 
expressed vimentin (d), while Oct 3/4 (a) and ??????f) were expressed to a 
lesser extent. CD45 (b), CD34 (c) and pancitokeratin (e) were absent. 
Figure 3 
A. Photographs of embryonic lung explants taken at the beginning of the 
culture, at 24 h, 48 h and 72 h. Nitrofen-exposed embryonic lungs were 
markedly hypoplastic (second column) in comparison with controls and 
they were not influenced by their co-culture with basophils (fifth column). 
In contrast, AFSC rescued growth of nitrofen-exposed lung explants both 
when co-cultured with lungs (third column) and when injected in the 
amniotic fluid (sixth column). A similar effect was obtained by adding RA to 
the medium (fourth column). Scale bar: 0.5 mm. 
Growth parameters (B and C) and peristalsis (D) analysed in lung explants 
after 72 hours of culture. The lung surface (B), the number of terminal bud 
(C) and the number of contractions per minute (D) were decreased in 
nitrofen-exposed lungs and restored to control values in presence of RA or 
AFS cells. This was also the case of the nitrofen-exposed lungs transplanted 
with AFS at E10.5.  (# p<0.05 vs control) 
The presence of basophils did not influence the growth or functional 
movement of the embryonic lungs, which remained impaired. 
Figure 4 
A. PGP9.5 protein level normalized to super-oxide-dysmutase (SOD) in 
Control, N, N+RA, N+AFSC groups. The expression of PGP 9.5 was 
decreased in nitrofen-exposed explants (# p<0.05 vs control). The 
expression normalized adding RA to the medium or co-culturing the 
nitrofen-exposed lungs with AFS cells. B. ?-actin protein expression 
     
 
normalized to SOD. No differences were seen in the levels of the protein in 
the four study groups. 
Figure 5  
Confocal projections of nitrofen-exposed lung cultured after in utero AFS 
cells transplantation. GFP+ AFS cells (green) were diffusely present on the 
bronchial tree,  but they did not colocalized with ?-actin- (A) or PGP9.5- (B) 
positive cells (red). 50-70% of GFP+ AFS cells colocalized with the alveolar 
epithelial TTF-1-(C and D) positive cells (red). Scale bar (A, C?????????????????
bar (B, D????????? 
Figure 6 
FGF10 (A??? ?????? ?B?? ?????????? ?C) mRNA expression in the medium of 
nitrofen-exposed lung explants co-cultured with AFS cells compared with a 
???????? ????? ?????????????????????? ??????? ??? ?????? ???? ????????????? ????
respectively a promoter of branching morphogenesis and a promoter of 
vasculogenesis, ????????????????????????????????????????????????????????????
lung epithelial proliferation and differentiation, was similar to controls. 
    
 
Figure 1 
 
 
 
 
 
 
 
 
 
     
 
Figure 2 
 
 
 
 
 
 
 
 
    
 
Figure 3 
 
    
 
Figure 4 
 
 
    
 
Figure 5 
 
 
 
 
 
 
 
 
    
 
Figure 6 
  
 Discussion
     DISCUSSION 
  
86 
 
Congenital diaphragmatic hernia is a malformation that still causes high mortality in 
newborns mainly because of severe respiratory failure secondary to pulmonary 
hypoplasia. Unfortunately, most of the newer treatment modalities have replaced 
mortality for a higher morbidity. As a matter of fact, long-term pulmonary disease 
continues to be the most significant source of morbidity in survivors of CDH. Persistent 
lung hypoplasia with structural abnormalities in distal airways 
97, 98
 and barotrauma 
from neonatal intensive care treatment have been considered as possible causes of 
long-term pulmonary sequelae 
12, 18, 19, 99
. However, these children are prone to 
develop exacerbations secondary to viral respiratory infections and suffer from 
obstructive, restrictive or a combined ventilation impairment even when the 
pulmonary hypoplasia is mild to moderate 
10, 12, 13, 75, 100, 101
. This led us to believe that 
also other causes might contribute to pulmonary morbidity. Some authors suggested 
that structural changes in distal airways could justify pulmonary symptoms without 
involvement of autonomic nerve abnormalities 
18
. Because autonomic nerves control 
the bronchial smooth muscle tone and the tracheobronchial reflexes in lower 
respiratory tract, we hypothesized that impaired innervation might contribute to 
explain the long-term pulmonary symptoms. 
Congenital diaphragmatic hernia can be reproduced in rat pups by administrating the 
herbicide nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) to pregnant mothers. In 
this model, lung hypoplasia can be found in all pups and congenital diaphragmatic 
hernia in most of them. Since its first description by Iritani 
76
, the nitrofen rodent 
model of CDH has been extensively studied and has become a widely accepted tool 
which closely replicates many features of the human condition 
77, 78
. 
Using this setting, we first confirmed the neural crest origin of tracheobronchial neural 
cells by the positive staining with p75 antibody. Then, we could depict an AChe-
positive neural network in the tracheas of preterm fetuses with CDH and we compared 
them with the controls. As previously shown in adult rat trachea 
102
, the nerve fibers of 
control tracheas were interconnected to form plexuses containing ganglia and ran in 
the membranous wall sending nerve bundles laterally between the cartilaginous rings. 
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Interestingly, the neural network was sparser and the nerve trunks thinner in the 
tracheas of animals with CDH. Moreover, while the number of ganglia was similar in 
control tracheas and in the ones of pups with CDH, in the latter the surface of the 
ganglia was smaller. In addition, in the same tracheas PGP 9.5-protein levels were 
decreased, while PGP 9.5-mRNA expression was increased in comparison with 
controls. PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase isozyme L1 
103
 expressed 
over the development at all levels of the central and peripheral nervous system 
104
 in 
differentiated neurons and in nerve fibers as well as in neuronal precursors, leading to 
believe that it has a role in the development and differentiation of neuronal cells. PGP 
9.5 protein and PGP 9.5 mRNA have been demonstrated to have a parallel distribution 
in rat tissues 
105
, suggesting that the increase of PGP 9.5 mRNA in our setting could be 
due to post-translational events occurring in the development of CDH trachea. 
The deficiencies found in the tracheal innervation of near term CDH fetuses stimulated 
us to look further into the development of this innervation in the embryo-fetal period. 
Interestingly, we found that the pattern of innervation in embryos and fetuses with 
CDH was similar to the one depicted in CDH preterm pups, with poor neural 
interconnections and sparser nerve fibers. PGP 9.5 protein was decreased and PGP 9.5 
mRNA was increased throughout development. The immaturity of the tracheal 
innervation early in embryo-fetal life and its deficiency thereafter seemed to confirm 
the hypothesis of a delayed development occurring in animals with CDH. At the same 
time, we described an increased population of S100-positive glial cells in embryos and 
fetuses with CDH. S100 is a calcium-binding protein expressed in glial and Schwann 
cells 
106, 107
, whose increased expression has been interpreted as a compensatory 
mechanism for defective neural tissue 
108
. Hence, the increment of glial tissue in 
embryos and fetuses with CDH might be interpreted as either a response to neural 
damage or a compensation for the defective neuronal tissue. 
After demonstrating that tracheal innervation was abnormal in rats with CDH, the next 
step was to examine bronchopulmonary innervation assuming that it could also be 
impaired. Since we felt that, if abnormalities of bronchopulmonary innervation were 
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found also in babies with CDH, they could play a role in chronic lung disease of 
survivors of CDH, we investigated if a similar pattern could be found also in infants 
dead of CDH. The number of trunks per bronchus was significantly decreased in 
embryos and fetuses with CDH. Surprisingly, the findings in infants with CDH were 
quite similar and the pattern in preterm rats closely resembled the human one. As 
previously described for tracheal innervation, these deficits in bronchopulmonary 
innervation were consistent with the hypothesis that the development in animals and 
infants with CDH was delayed. Also in this case, the neural deficiency was 
compensated by a certain increase of the supporting glial tissue. S100 staining, that 
unveils the supporting glial cells of pulmonary ganglia, revealed similar increases also 
in the lungs of infants with CDH. To further support the hypothesis of a delayed 
development of the innervation, we studied the expression of RET, a receptor tyrosine 
kinase expressed by neural crest-derived cells during their migration and later required 
for the peripheral nervous system maturation 
109-111
. RET expression is high in neural 
crest cells during migration and in neural crest-derived structures during 
embryogenesis, whereas it decreases in mature tissue 
111
. Hence, its increased 
expression in lungs of infants with CDH could be explained as a persistence of the 
enteric neuron precursors, while the same cells were already differentiated in the 
correspondent controls. Unfortunately, for technical reasons, we were unable to 
analyze the expression of RET in rat lungs. RET activation depends on the presence of 
GDNF, that pilots the innervation and the differentiation of the enteric nervous system 
progenitors in the developing lung 
112, 113
. In addition, GDNF acts as chemoattractant of 
these progenitors and it is expressed by the mesenchyme before the entry of neural 
crest-derived cells 
114, 115
, whereas the response of the target cells to GDNF decreased 
in later stages of development 
116, 117
. The persistent increase of GDNF protein in lungs 
of preterm animals with CDH, like in earlier stages of development, gave further 
support to the hypothesis of a delayed development of innervation in which 
characteristics of the immature period were maintained. At the same time, the 
decrease of GDNF mRNA in the lungs of animals with CDH failed to compensate the 
deficit of neural tissue. Importantly, the lungs ipsilateral and contralateral to the 
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hernia were equally affected, supporting the concept that lung hypoplasia associated 
to CDH is a primary developmental defect rather than the result of lung compression 
during embryogenesis. 
Confocal microscopic studies 
40
 have shown that neural tissue and smooth muscle 
appear early in the developing fetal lung, being epithelial tubules surrounded by 
smooth muscle and ensheathed in a network of nerve plexus from embryogenesis 
onward, but, interestingly, this spatial and temporal association persists into postnatal 
life. Prenatal smooth muscle seems to have a pivotal role in modulating lung growth 
47
 
and the mechanical stimulus generated by its spontaneous phasic contractions 
contribute to a normal airway branching and differentiation. Taking into consideration 
that bronchial peristalsis is deficient in hypoplastic nitrofen-exposed rat lung explants 
47
 and that the tracheobronchial innervation is impaired in rat fetuses with CDH and 
lung hypoplasia, as we could demonstrate, we postulated that abnormalities in 
bronchial innervation might contribute to the pulmonary developmental deficiency. 
The lungs can be easily cultured in vitro and this has been very useful to investigate 
lung development, which can be influenced by altering the composition of the medium 
31, 36
. Using this setting, we could demonstrate that in the nitrofen-exposed lung 
explants in which the frequency of peristaltic waves was decreased, the levels of PGP 
9.5 were decreased as well. It has been observed that spontaneous contractions of the 
airways are unaffected by either atropine, indicating that neural activity is not 
essential, or tetrodotoxin, showing that endogenous Ach is not involved 
36
. In addition, 
this rhythmic mechanical activity ceases in the presence of calcium antagonists. It has 
been concluded that spontaneous contractions are therefore of likely of myogenic 
origin 
36
. Hence, it has been supposed that the role fulfilled by neural tissue in early 
gestation is not neurotransmission, but rather secretion of trophic factors for the 
smooth muscle that indirectly contributes to lung development 
33, 36, 39, 40
. The same 
authors 
36, 40, 43
 proposed the idea that the spontaneous contractions produce a 
rhythmic mechanical stimulus across the airway wall and the adjacent parenchyma 
that contributes to normal airway differentiation and branching by inducing expression 
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of growth factors. Neurotrophic factors, like neurturin, a member of GDNF-family, and 
GDNF, have been isolated in airway smooth muscle cells or in the associated 
mesenchymal cells 
31, 44, 45
. In this light, the decrease of neural structures, revealed by 
the reduced amount of PGP 9.5-positive cells, might cause an impairment of the 
signalling between nerves and airway smooth muscle, contributing to the hypoplasia 
of the lung. In addition, it has been shown recently that innervation is required for 
epithelial progenitor cell function during organogenesis, because removal of the 
parasympathetic submandibular ganglion before the homonymous gland developed in 
mice, impaired its development reducing the number of epithelial buds by weakening 
the expression of progenitor cells 
118
. The same coordinated development of the 
peripheral nervous system and a branched epithelium organ is likely in the lung. 
Moreover, basal progenitor cells express the nerve growth factor receptor (NGFR), 
whose function to date has not been clarified 
119-121
. 
Given these observations, we expected that agents like RA, that has been shown to 
have beneficial effects on CDH lungs in which it is able to rescue lung hypoplasia 
48, 56, 
57, 61, 122
, may also positively influence bronchial innervation and peristalsis. Despite 
evidence linking retinoids with CDH dating back more than 50 years 
54
, only lately they 
have been related to the pathogenesis of pulmonary hypoplasia associated with CDH 
56, 61, 63, 77, 123
. Plasma concentration of retinol and of retinol-binding protein (RBP) have 
been found decreased in newborns with CDH in comparison with controls. Those 
values were independent of maternal retinol status that was similar to controls for 
some authors 
124
, while higher than controls for others 
125
. These findings supported 
the idea that human CDH is linked to abnormal retinoid homeostasis. It has been 
demonstrated that exogenous retinoic acid is able to increase the size of hypoplastic 
lung explants 
61, 63-65
. Moreover, RA induces FGF10 expression in the foregut region 
where the lung forms 
95
. Thus, since FGF10 governs the directional outgrowth of lung 
bud during branching morphogenesis 
126
, RA signaling may connect formation of the 
laryngo-tracheal groove with activation of FGF10-dependent bronchial morphogenesis 
93
. FGF10 is produced by airway smooth muscle progenitors and is required for their 
entry into the smooth muscle cell lineage 
127
. 
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In our experiments, RA not only significantly increased lung growth in nitrofen-exposed 
lung explants, as previously demonstrated 
61
, but it restored the hypoplastic lungs to 
the size, the number of terminal buds and the DNA and protein content of the control 
lungs. The frequency of peristaltic waves, that was decreased in nitrofen-exposed 
lungs, normalized adding RA to the medium. The improvement of airway peristalsis 
obtained with RA was not related to smooth muscle hypertrophy, because the 
expression of smooth muscle-specific marker ?-actin was not increased in RA treated 
groups. On the other hand, the levels of the pan-neuronal protein PGP 9.5, that was 
decreased in nitrofen-exposed lung explants, were restored by RA. RA signalling has 
been found to play a role in neurite outgrowth both in vitro and in vivo 
128
. However, 
limitations for the clinical use of RA, which is known to be teratogenic 
79, 80
, invite to 
explore alternative procedures for the rescue of this devastating disease. 
Stem cell-based therapies are becoming promising approaches for a large number of 
diseases. Recently, it has been reported that AFS cells can be isolated from human and 
rodent amniotic fluid. AFS cells are broadly multipotent cells, able to differentiate into 
lineages belonging to all three embryonic germ layers 
66
. Moreover, they can also 
engraft in irradiated bone marrow and give rise to all hematopoietic lineages 
67
. Finally, 
they can functionally contribute to the regeneration of various tissues and organs 
when transplanted into animal models of disease. Remarkable results have been 
obtained in injured kidneys, heart and lungs 
68-70
. The latter have been explored both 
in models of diseases and during development and AFS cells have shown the potential 
not only to engraft and differentiate into specialised pneumocytes but also to 
contribute and supplement endogenous lung repair mechanisms 
71
. 
We found that hypoplastic nitrofen-exposed lung explants co-cultured with AFS cells 
were restored to the size and number of terminal buds equivalent to those of control 
lungs. Moreover, the frequency of peristaltic waves, that was decreased in nitrofen-
exposed lungs, normalized after adding AFS cells to the medium. The improvement of 
airway peristalsis obtained with AFS cells, similarly to what we found with RA, was not 
related to smooth muscle hypertrophy 
82, 83
, because the expression of smooth muscle-
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specific marker ?-actin was not increased in AFS cells treated group. In contrast, the 
levels of PGP 9.5 were decreased in nitrofen-exposed lungs and they normalized after 
adding the AFS cells to the medium. 
In order to mimic a possible therapeutic approach potentially viable in the clinical 
setting, we subsequently tested whether AFS cells could be beneficial on the lungs of 
the fetuses when injected directly into the ambiotic fluid one day after the 
administration of nitrofen to pregnant rats. Indeed lung growth and motility, evaluated 
after harvesting and culturing the embryonic lungs, could be rescued when AFS cells 
were administered in this manner. This could be observed in spite of a high rate of in 
utero embryonal mortality, being the overall survival 15%. To determine whether AFS 
cells were able to differentiate into neural, muscle or epithelial lineages after 
integration, we analyzed the colocalization of GFP+ AFSC with PGP9.5+ or ?-actin+ or 
TTF-1+ cells. We found that AFS cells colocalized with alveolar epithelial TTF-1+ cells. 
Despite the minimal indication of engraftment, the main therapeutic effect produced 
by AFS cells seems mediated by paracrine mechanisms elicited through trophic 
mediators 
72, 84-88
, as evident by the co-culture experiments. Among the various factors 
that could be driving this effect, FGF???? ?????? ???? ?????? ??re evaluated in this 
study. FGF10 is essential for lung branching morphogenesis having a central role in 
????????? ???????????? ?????????????????????????????????????????? ???????????????????????
these effects preventing local budding and maintaining proximal airways in an 
unbranched form by suppressing epithelial cell proliferation and by promoting 
?????????? ??? ?????????????? ??????? ??????????? ??????? ????????? ?????? ??? ?? ???????
promoter of angiogenesis and its signalling is responsible for the differentiation of 
embryonic mesenchymal cells into endothelial cells; the interaction between the 
epithelium and mesenchyme contribute to lung neovascularisation that is crucial in 
normal lung development 
26, 89-93
. Interestingly, we found that the levels of FGF10 and 
?????? secreted by AFS cells were increased in comparison with controls when 
nitrofen-exposed lung explants were co-cultured with AFS cells. These findings were 
consistent with the demonstration that the temporo-spatial pattern of FGF10 
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expression is severely disrupted in the presence of nitrofen-induced lung hypoplasia, 
whereas exogenous FGF10 can rescue hypoplastic lungs in culture 
94
. This is also 
consistent with the fact that it has recently been shown that also RA has a major role 
in early lung morphogenesis by inducing FGF10 expression within the mesoderm 
subjacent to the site of origin of the laryngotracheal groove 
95
. It is likely that AFS cells 
are capable to produce high levels of FGF10 when they are in a damaged lungs setting 
96
. 
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1. Tracheal innervation of preterm rat fetuses with nitrofen-induced CDH is 
deficient in terms of decreased density of neural structures and surface of 
ganglia. 
2. The deficits of tracheal innervation in rat embryos and fetuses with CDH are the 
consequence of an abnormal development in terms of delay and neural 
damage. 
3. The bronchopulmonary innervation is deficient both in rats and in infants with 
CDH because of a delayed development with persistence of the enteric neuron 
precursors, that is compensated by a certain increase of the supporting glial 
tissue. The latter has been interpreted as a response to neural damage and 
compensation for the defective neuronal tissue. 
4. Both in animals and in infants with CDH the lung ipsilateral and contralateral to 
the hernia are equally affected, supporting the concept that lung hypoplasia 
associated with CDH is a primary developmental defect. 
5. In cultured, nitrofen-exposed lung explants in which the frequency of peristaltic 
waves is decreased, the bronchial neural tissue is deficient as well. 
6. The deficient bronchial neural tissue in the explanted rat hypoplastic lungs is 
rescued, together with airway peristalsis and lung growth, by retinoic acid. 
7. Amniotic fluid stem cells rescue lung growth, airway peristalsis and bronchial 
neural tissue when co-cultured with nitrofen-induced hypoplastic rat lungs. 
8. When co-cultured with nitrofen-induced hypoplastic lungs, amniotic fluid stem 
cells secrete increased amounts ??????????????????? 
9. Lung growth and motility are rescued when AFS cells are injected intra-
amniotically to nitrofen-exposed pregnant rats. 
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1. La inervación traqueal de los fetos pretérmino con hernia diafragmática 
congénita, causada mediante administración de nitrofen a la madre, es 
deficiente en términos de una menor densidad de estructuras nerviosas y de 
una disminución de la superficie de los ganglios. 
2. Los defectos de la inervación traqueal en embriones y fetos con hernia 
diafragmática congénita son el resultado de un retraso en el desarrollo y de 
daño del tejido nervioso. 
3. La inervación broncopulmonar es deficiente tanto en ratas como en niños 
recién nacidos con hernia diafragmática congénita debido a un retraso en el 
desarrollo con persistencia de los precursores de las neuronas entéricas, que se 
compensa con un cierto aumento del tejido glial de soporte. Este último ha sido 
interpretado como una respuesta al daño neuronal y una compensación del 
defecto de estructuras nerviosas. 
4. Tanto en animales como en recién nacidos con hernia diafragmática congénita 
el pulmón ipsilateral y el contralateral a la hernia se ven igualmente afectados, 
apoyando el concepto de que la hipoplasia pulmonar asociada con la hernia 
diafragmática congénita es un defecto primario de desarrollo. 
5. En los explantes expuestos al nitrofen cultivados, en los cuales la frecuencia de 
las ondas peristálticas está disminuida, también el tejido neural bronquial es 
deficiente. 
6. La deficiencia del tejido nervioso bronquial en los pulmones hipoplásicos de 
rata explantados es rescatado, junto con la peristalsis de las vías aereas y el 
crecimiento del pulmón, por el ácido retinoico. 
7. Las células madre de origen amniótico son capaces de rescatar el crecimiento 
del pulmón, la peristalsis de las vías aereas y el tejido nervioso bronquial 
cuando se co-cultivan con los pulmones hipoplasicos de ratas expuestas al 
nitrofen. 
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8. Cuando se co-cultivan con los pulmones hipoplasicos expuestos al nitrofen, las 
células madre de origen amniótico secretan una mayor cantidad de FGF10 y de 
VEGF?. 
9. El crecimiento y la peristalsis de los pulmones hipoplásicos son rescatados 
cuando se inyectan células madre de origen amniótico en la cavidad amniótica 
de ratas preñadas expuestas al nitrofen. 
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